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Abstract 
In eukaryotes, the timing of cell cycle events and transitions is controlled via substrate 
phosphorylation and dephosphorylation, by kinases and phosphatases. In budding 
yeast, the ratio of Cdk kinase/Cdk-opposing phosphatase activity regulates mitotic exit 
by controlling the timing of substrate dephosphorylation in a quantitative manner.  
The main mitotic exit phosphatase in budding yeast is Cdc14. In interphase and early 
mitosis, Cdc14 is sequestered in the nucleolus through inhibitory binding to Net1, from 
which it is released in early anaphase. At this time, Net1 is phosphorylated by Cdk (thus 
relieving its inhibition of Cdc14), an event promoted by proteins of the Cdc14 Early 
Anaphase Release (FEAR) network. Later in anaphase, the Mitotic Exit Network 
(MEN) signaling cascade maintains Cdc14 release. We have yet to understand how 
Cdc14 activity can increase in early anaphase, while Cdk activity, that is required for 
Net1 phosphorylation, decreases and the MEN is not yet active. I show that the nuclear 
rim protein Nur1 interacts with Net1 and, in its Cdk phosphorylated form, inhibits 
Cdc14 release. Cdc14 dephosphorylates Nur1 in early anaphase, relieving the inhibition 
and promoting further Cdc14 release. Nur1 dephosphorylation thus describes a 
positive feedback loop in Cdc14 phosphatase activation during mitotic exit. 
The importance of Cdk-opposing phosphatase activity in mitotic exit is established, but 
it is postulated that similarly, Cdk-opposing phosphatase activity in interphase could be 
an important element in a quantitative model for cell cycle progression. In budding 
yeast, PP2A, Cdc14, and PP1 are candidates for such a phosphatase. In the absence of 
PP2ACdc55, global interphase Cdk phosphorylation levels are elevated, independently of 
PP2A’s role in regulating Cdk tyrosine phosphorylation. Strikingly, absence of 
PP2ACdc55 leads to a specific increase in threonine over serine Cdk phosphorylation. I 
have also identified specific Cdk targets whose phosphorylation is advanced and 
increased in this case. This indicates that PP2ACdc55 may be directly opposing Cdk 
phosphorylation events throughout interphase, from G1 until the onset of mitosis, thus 
forming a part of a mechanism that sets Cdk thresholds for cell cycle progression. The 
roles of PP1 and Cdc14 in interphase remain as yet undetermined.     
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Chapter 1. Introduction 
1.1 Cell division is a fundamental and conserved process 
“The dream of every cell is to become two cells”, according to the molecular biologist 
and Nobel-prize winner Francois Jacob (Monod and Wainhouse, 1971), and this 
“dream” is the fundamental priniciple driving all living organisms, the essential 
condition for life itself. Since the cell theory was formulated in the 19th century, we have 
tried to understand how cell division works, which external and internal factors 
influence how, when, and why, cells divide.  Although we can now claim to have a good 
overall grasp of the control of cell division in organisms ranging from the simple to the 
complex, from bacteria to yeast, frogs to fish, birds to mammals, a detailed and 
complete understanding of the molecular mechanisms involved remains beyond our 
reach.   
In this thesis, using the baker’s yeast Saccharomyces cerevisiae as a model organism, I 
have aimed to provide my own contribution to the field of cell division research, 
building on previous knowledge to provide an ever-clearer picture of how cells 
reproduce.   
1.1.1 The eukaryotic cell cycle 
In order to reproduce,  a “parent” cell first needs to grow in size and duplicate its 
contents, and then divide cellular components equally between two newly-formed 
distinct entities known as “daughter” cells. The tightly regulated series of events 
occuring during these processes forms the cell cycle, which can be divided into several 
phases. Fundamental to this process is the need to replicate the DNA (in the form of 
chromosomes), and then separate the newly replicated genetic material equally and 
accurately between the daughter cells. These processes occur respectively during the 
“synthesis” or S phase and at mitosis or M phase.  
Mitosis can be further subdivided into metaphase, anaphase and telophase, and is 
followed by cytokinesis, during which the daughter cells separate. These phases are 
Chapter 1 Introduction 
 19 
separated by gap phases (G1 and G2) required for cellular growth and the replication of 
organelles (Fig. 1.1). The G1, S and G2 phases separating successive mitoses are 
collectively known as interphase (Forsburg and Nurse, 1990; Morgan, 2007).  
These basic events, and the order they occur in, are conserved in all eukaryotic cells. 
The details of cell cycle regulation and time spent in gap phases vary. Further, there are 
variations in the symmetry of cell division and whether or not the nuclear envelope 
breaks down (open vs. closed mitoses) between different organisms, and in the case of 
the former, within organisms.  
1.1.2 The cell cycle of the budding yeast Saccharomyces cerevisiae 
Saccharomyces cerevisiae, a simple fungal unicellular organism, has emerged over the 
last 40 years as an advantageous model system to study cell cycle regulation (Hartwell, 
1974; Forsburg and Nurse, 1990). Basic cell cycle events and the way these are regulated 
are conserved between yeast and other eukaryotic systems. Indeed, the cell cycle is 
controlled, to a large degree, by structural and functional homologues of the same basic 
set of proteins in humans and in yeast (Morgan, 2007). Their speed of replication, and 
amenability to genetic manipulation, the availability of well-developed techniques and 
their low cost of use, as well as their simplicity, make yeast a good model organism and 
basic research tool.  
The particulars of the budding yeast cell cycle involve asymmetric cell growth and 
division, and a closed mitosis, with no breakdown of the nuclear envelope (Fig. 1.1). 
The genome, around 12 Mb long and spread over 16 chromosomes, is replicated in S 
phase, with sister chromatids undergoing a process of condensation throughout G2 and 
metaphase, and being segregated in anaphase. Spindle pole bodies duplicate in early S 
phase and the bipolar spindle forms at the G2/M transition, aligning itself across the 
nucleus and elongating throughout mitosis in order to drag sister chromatids apart. 
The spindle then breaks down in telophase. 
 At 25°C, the doubling time for wild type budding yeast cells growing exponentially 
under optimal conditions is around 90 minutes. Cells spend the majority of this time 
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alternating between S phase (approximately 20-30 minutes) and mitosis (approximately 
45-50 minutes, more or less equally divided between metaphase and anaphase, with 
telophase and cytokinesis being very brief).  
 
Figure 1.1 – The budding yeast cell cycle 
The eukaryotic cell cycle is composed of S phase, during which chromosomes are 
replicated, and M phase, during which they are separated and at the end of which cell 
division occurs. S phase and M phase are separated by periods of cell growth, known as 
gap phases (G1 and G2). In budding yeast, cell division is asymmetric and the daughter 
cell is formed by budding from the mother cell. The nuclear envelope does not break 
down during mitosis. DNA in the form of uncondensed (G1-S-G2) and condensed (M) 
chromosomes is represented in blue, inside the nucleus, and the spindle and spindle 
pole bodies are in green. The approximate times spent in each phase of the cell cycle in 
cells growing exponentially at 25°C is indicated.  
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As in other eukaryotes, two proteins, both ring shaped complexes composed of 
members of the SMC family of proteins, provide the structural integrity to condensed, 
mitotic chromosomes – Condensin and Cohesin. Condensin (and to some extent 
Cohesin) is responsible for condensing the chromosomes, providing them with enough 
rigidity and identity to allow them to be organised into distinct sister chromatids 
(Thadani, Uhlmann and Heeger, 2012). Cohesin holds the replicated sister chromatids 
together from the end of S phase until anaphase, when it is cleaved, allowing them to 
segregate to opposite poles of the cell (Haering, Löwe, Hochwagen and Nasmyth, 2002; 
Uhlmann, Lottspeich and Nasmyth, 1999; Marston, 2014). 
1.1.3 Cell cycle checkpoints 
Cells must ensure that their DNA is accurately copied and chromosomes equally 
partitioned between two cells in order to preserve ploidy and integrity of the genome.  
Therefore S phase and mitosis must be temporally regulated to occur only once each 
cell cycle, and any errors in replication or segregation need to be rapidly detected. 
Moreover, the cell needs to make sure that external conditions are favourable before 
commiting to cell replication. This is accomplished via checkpoints throughout the cell 
cycle, the principles and players behind which are highy conserved (Hartwell and 
Weinert, 1989; Elledge, 1996; Morgan, 2007).  
The first checkpoint regulates entry into the cell cyle, and is known as the G1 or 
restriction checkpoint in higher eukayotes, or START, in yeast (Cross, 1995; Pardee, 
1974). At this point, cells decide whether or not to commit to a round of replication, a 
decision dependent on exogenous influences. In yeast, commitment depends mainly on 
enviromental factors, whereas in human cells it is more likely to be triggered by growth 
factors.  
DNA integrity is monitored both before replication, at the G1/S transition, and before 
mitosis, at the G2/M transition – the cells “check” that the chromosomes have been 
properly replicated before entering into mitosis (Gerald, Benjamin and Kron, 2002). 
Budding yeast also have a morphogenesis checkpoint, where bud formation and correct 
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cell polarity is monitored (Lew and Reed, 1995). Finally, the “mitotic” or “spindle 
assembly” checkpoint ensures that the chromosomes are correctly bi-oriented and 
under tension from the spindle, ensuring accurate chromosome segregation 
(Musacchio and Salmon, 2007; May and Hardwick, 2006). 
1.2 Cell cycle control by Cyclin-Cdk complexes 
1.2.1 Cell cycle progression is controlled by Cdc28 associated with a 
series of cell cycle stage-specific cyclins 
Cyclin-dependent kinases (Cdk’s) are the master regulators of the eukaryotic cell cycle. 
In complex with regulatory molecules known as Cyclins, which provide substrate 
specificity and stimulation of kinase activity, they control the ordering of cell cycle 
events. Cdk’s are proline-directed serine/threonine phosphatases, phosphorylating the 
Cdk consensus site motif S/TP(xR/K), with the +3 lysine/arginine preferred but not 
essential (Holmes and Solomon, 1996). They control cell cycle progression by 
phosphorylating, and thereby activating/inactivating, stabilising/destabilising, target 
proteins, actions that are necessary for the completion of cell cycle events in the right 
order. In budding yeast, there is only one Cdk, known as Cdc28, and 9 different Cyclins, 
which can be subdivided into three groups: G1 cyclins, Cln1,2,3; S phase cyclins; Clb5,6; 
and M-phase Cyclins, Clb1,2,3,4 (Bloom and Cross, 2007a; Morgan, 2007). Cdc28 
associates with the different cyclins at the appropriate cell cycle stages, allowing the 
thus formed Cyclin-Cdk complex to phosphorylate the correct target proteins.  
G1 Cyclin-Cdk complexes are necessary for licensing the duplication of the spindle pole 
bodies, promoting emergence of the bud and transcription of the S-phase cyclins. S 
phase Cyclin-Cdk complexes promote DNA replication and transcription of the mitotic 
cyclins, which themselves allow for spindle formation, and promote the G2/M 
transition and other early mitotic events. Mitotic cyclins also inhibit mitotic exit events 
from occurring (Bloom and Cross, 2007a) (Fig. 1.2). They are degraded at the 
metaphase-to-anaphase transition, at which point Cdk activity drops dramatically in 
order to allow for mitotic exit to occur.  
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Figure 1.2 – Budding yeast Cyclin-Cdk complexes in the cell cycle 
Budding yeast cyclins associate with a single Cdk (Cdc28) at different cell cycle stages, 
during which they promote specific cell cycle events and transitions. From (Bloom and 
Cross, 2007a). 
 
Although this is a simpler system than that present in higher eukaryotes, where 
multiple Cdk’s exist as well as multiple cyclins, the principle remains the same: cell 
cycle stages are associated with specific Cyclin-Cdk complexes. As such, it was long 
assumed that the ordered progression through cell cycle stages was controlled by the 
specificity of substrates for the different Cyclin-Cdk complexes.  
Indeed, supporting this hypothesis, it has been demonstrated in mammalian systems 
that G1 Cyclin-Cdk complexes have a biochemical preference for a small number of 
substrates (Kitagawa et al., 1996). In this same system, the existence of an S-phase 
specific recognition motif termed the RxL peptide was discovered, which is recognised 
by a hydrophobic patch on human S-phase cyclin (Adams et al., 1996). Strikingly, the 
role of the hydrophobic patch/RxL motif in conferring a biochemical preference of S 
phase Cdk-Cyclins for S-phase substrates was confirmed in budding yeast, in a large-
scale survey of 150 Cdk substrates (Loog and Morgan, 2005). Further, in budding yeast, 
an “LP motif” has been identified as a docking site within the G1 Cln1/2-Cdk target 
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Sic1, promoting phosphorylation by the latter (Kõivomägi et al., 2011). The same study 
identified several targets that seem to be specific for respectively G1, S and M cyclins. 
An attempt to pinpoint specific substrates of the different Cyclin-Cdk complexes by 
screening Xenopus leavis cDNA libraries resulted in the identification of around 40 
substrates each of Cyclin B-Cdk1 and Cyclin E-Cdk2 complexes (Errico et al., 2010). 
Similarly, in vivo pull-downs of Cyclin-Cdks in complex with their substrates at the 
different cell cycle stages led to the identification of a range of G1, S or M phase Cdk 
targets (Pagliuca et al., 2011). 
1.2.2 A quantitative model for cell cycle control 
However, despite this apparent “Cyclin-specificity”, cyclins themselves are mainly 
interchangeable. As such, in budding yeast, cells deleted for all of the B-type cyclins 
(clb1-6Δ), usually inviable, can be rescued by the ectopic expression of a single mitotic 
cyclin (Clb1) (Schwob, Böhm, Mendenhall and Nasmyth, 1994) .  
Further, cells lacking any two out of three of the G1 cyclins are also viable. In fact, cells 
lacking all three G1 cyclins are, likewise, viable when their deletion is combined with 
that of the Cdk inhibitor Sic1, a specific inhibitor of Clb-Cyclin complexes. In the 
absence of Sic1, Clb-Cdk complexes are able to initiate Start and promote the G1/S 
transition, indicating that Cln and Clb type cyclins are substitutable (Tyers, 1996).  
Cells deleted for the S-phase cyclins Clb5 and 6 have a delay in S-phase and the 
initiation of DNA replication, which is not rescued by the expression of the main 
mitotic cyclin Clb2 from the Clb5 promoter, supporting the hypothesis that cyclin 
specificity is the main driver for correct cell cycle progression (Cross, Yuste-Rojas, Gray 
and Jacobson, 1999). However, it has now been shown that deletion of the Cdk 
inhibitor Swe1, which has a strong preference for inhibiting Cdk in complex with the 
mitotic cyclin Clb2, enables Clb2, expressed under control of the Clb5 promoter, to 
initiate DNA replication with similar efficiency to Clb5. Indeed, in a strain lacking all of 
the other Clb’s and Swe1, the early expressed Clb2-Cdk1 is able to phosphorylate all 
essential Clb-Cdk substrates with virtually wild-type timing (Hu and Aparicio, 2005).  
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Similarly, in animal cells, only one, mitotic, Cdk-Cyclin complex is essential – Cdk1-
Cyclin B (out of at least 10 Cdk’s and at least fourteen Cyclins) (Santamaría et al., 2007; 
Pagliuca et al., 2011; Kalaszczynska et al., 2009).  
Despite the identification of specific substrates for Cyclin B-Cdk1 and Cyclin E-Cdk2 in 
X. leavis, further study of the in vitro substrate specificity of these Cyclin-Cdk 
complexes indicates that the great majority (90%) of substrates were phosphorylated 
with similar affinity by both kinases.  In silico analysis could not find any defining 
factor between one group of substrates and the other (Errico et al., 2010). Further, 
although cell cycle specific substrates of different Cyclin-Cdk complexes were identified 
by Pagliuca et al, with a range of substrates interacting only with one Cyclin-Cdk 
complex, this could be due to the presence of each specific complex at different cell 
cycle stages and with different localisations, combined with the fact that the pull-downs 
were carried out in vivo at these specific stages (Pagliuca et al., 2011).  
In addition to this, evidence from fission yeast, in which a single (mitotic) Cyclin-Cdk 
complex, Cdc13-Cdc2 (Cyclin B-Cdk1), is able to substitute for all others, indicates that 
perhaps cyclin specificity is not, after all, the main driver for the temporal organisation 
of cell cycle stages. As such, it was shown some 20 years ago that the oscillations in 
activity of the Cdc13-Cdc2 complex, in the absence of G1 and S-phase cyclins, could 
promote both DNA replication and mitosis, and in the correct order (Fisher and Nurse, 
1996). This finding led Stern and Nurse to propose their cell cycle model in which 
rising levels of activity of the Cdk complex, rather than cyclin subunit identity, control 
the timing of cell cycle events (Stern and Nurse, 1996) (Fig. 1.3A). 
This model, for quantitative control of the cell cycle by Cdk’s, was a seminal 
contribution to the field of cell cycle studies. Its strength was reasserted in a series of 
more recent experiments in fission yeast, in which a genetically engineered Cyclin-Cdk 
complex, composed of a fusion of Cdc2 and Cdc13 (expressed under the Cdc13 
promoter), and a mutation rendering Cdc2 sensitive to chemical inhibition by the ATP 
analogue 1-NMPP1, was used. This complex is controlled through addition of the 
inhibitor in a dose-dependent manner, and is naturally degraded at the 
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metaphase/anaphase transition (due to the fusion with the B-type cyclin Cdc13). Low 
levels of activity trigger S phase, and high activity causes mitotic entry, whether S phase 
has been completed or not. Changing Cyclin-Cdk levels is sufficient to overcome cell 
cycle checkpoints as well as alter the directionality of the cell cycle (Fig. 1.3B).  
In further support of this theory, a quantitative model for the ordering of mitotic events 
also holds true.  In budding yeast, it was demonstrated through titration of the levels of 
Clb2-Cdc28 that mitotic events require increasing concentrations of this complex with 
relation to their time of incidence. As such, different thresholds of Cdc28-Clb2 activity 
are required for spindle formation in metaphase and for spindle elongation at anaphase. 
Further, increasing Clb2-Cdc28 concentration to higher than endogenous levels is 
sufficient to accelerate mitosis (Oikonomou and Cross, 2011). This “Cdk threshold” 
model has also been validated in mammalian cells (Deibler and Kirschner, 2010). Exit 
from mitosis, in this quantitative model for the cell cycle, depends on the rapid drop in 
Cdk activity resulting from Cyclin degradation (Wäsch and Cross, 2002) (Fig. 1.3A).  
 
 
Figure 1.3 – A quantitative model for the cell cycle 
A. A quantitative model for cell cycle control, where rising Cdk levels control 
progression through the different phases of the cell cycle, as well as through mitosis. 
Adapted from (Stern and Nurse, 1996) B. The cell cycle lacks core directionality –  S 
phase does not need to have been completed for M phase to occur, and cells 
reciprocally do not need to have exited mitosis in order to perform S phase again. The 
only dependence is on the quantitative levels of qualitatively the same Cdc13-Cdc2 
complex (Adapted from (Coudreuse and Nurse, 2010)).  
A B 
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1.3 A focus on budding yeast mitotic exit 
1.3.1 Key events in budding yeast mitotic exit 
At anaphase onset, Cdk activity begins to drop as the Anaphase Promoting 
Complex/Cyclosome (APC/C) targets cyclins for degradation (Wäsch and Cross, 2002). 
The activation of the APC/C itself is dependent upon the inactivation of the Spindle 
Assembly Checkpoint or Mitotic Checkpoint, which monitors that the chromosomes 
are correctly attached to the mitotic spindle via microtubule/kinetochore interactions. 
APC is activated by phosphorylation by Clb-Cdk, with Clb-Cdk complexes thus 
promoting their own inactivation once they have reached their highest threshold of 
activity (Rahal and Amon, 2008). 
This triggers the sequence of events composing mitotic exit. One of the first proteins to 
be degraded by the APC, in complex with its Cdc20 regulatory subunit, is the securin 
Pds1. Pds1 degradation allows the activation of the protease Separase (Esp1 in budding 
yeast), which then goes on to cleave the Cohesin ring (Uhlmann, Lottspeich and 
Nasmyth, 1999). Cohesion between the sister chromatids is therefore dissolved, which 
then allows them to be pulled by the now rapidly elongating spindle to opposite ends of 
the cell.  
In budding yeast, Cdk activity persists in early anaphase. Although Clb5 is rapidly 
degraded upon anaphase onset, leading to an initial drop in Cdk activity, only a small 
fraction of Clb2 is degraded upon the activation of APCCdc20 (Nasmyth, Shirayama, Tóth 
and Gálová, 1999; Bäumer, Braus and Irniger, 2000). The bulk of Clb2 degradation in 
fact begins slightly later, when Cdc20 is replaced by Cdh1 – this protein being 
phosphorylated and inhibited from associating with APC until late anaphase 
(Jaspersen, Charles and Morgan, 1999). After this, the rest of Clb2 is degraded, Cdk 
activity falls further, the chromosomes decondense and the spindle disassembles in 
telophase.  
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1.3.2 The Cdk-opposing phosphatase Cdc14 is the major player in 
budding yeast mitotic exit 
The fall in Cdk activity is not sufficient, by itself, to drive mitotic exit. Instead, it is 
accompanied by a rise in the activity of Cdc14, a Cdk-counteracting phosphatase. 
Cdc14 was first identified as cell cycle regulator of which mutants arrested in late 
anaphase by Lee Hartwell in 1971 (Culotti and Hartwell, 1971). However, its role as the 
major player in budding yeast mitotic exit was not recognised for another 25 years, at 
which point it became apparent that Cdc14 triggers mitotic exit by directly 
dephosphorylating Cdk substrates (Visintin et al., 1998). 
 One of the main targets of Cdc14 is the Cdk inhibitor Sic1, which is stabilised upon its 
dephosphorylation. Another important target of Cdc14 is Cdh1, allowing for full 
activation of the APC (Jaspersen, Charles and Morgan, 1999). This allows for a dual 
regulation of Cdk activity – both by degradation of Cyclins and inhibition by Sic1. 
Indeed, it is the concomitant degradation of cyclins (causing the drop in Cdk activity) 
along with the re-accumulation and reactivation of Sic1, that make the M/G1 transition 
irreversible (López-Avilés, Kapuy, Novak and Uhlmann, 2009). Aside from that, Cdc14 
is essential for the regulation of all mitotic exit events up to and including cytokinesis, 
dephosphorylating many if not all Clb-Cdk substrates during this cell cycle phase. As 
such, it not only brings about mitotic exit but also “resets” the cell cycle for the next G1.  
 Amongst others, its targets include Ask1, Fin1 and Sli15, their dephosphorylation 
necessary for spindle stability. It also targets Orc6, in order to relicense replication in 
the next cell cycle, as well as the replication factors Sld2 and Dpb2. Finally, it can also 
dephosphorylate proteins involved in cytokinesis, such as Inn1, to promote accurate 
bud neck formation (Higuchi and Uhlmann, 2005; Bouchoux and Uhlmann, 2011; 
Mirchenko and Uhlmann, 2010; Woodbury and Morgan, 2007; Bloom and Cross, 
2007b; Sanchez-Diaz, Nkosi, Murray and Labib, 2012).  
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1.4 The activity of Cdc14 is stringently regulated 
Given the importance of Cdc14 for mitotic exit, its high affinity for Cdk substrates, and 
its Cdk-opposing activity, it needs to be regulated so that it is only present and active in 
the cell during a short time-window. As such, during most of the cell cycle, Cdc14 is 
kept sequestered and inactive in the nucleolus through inhibitory binding to the rDNA-
associated protein Net1 (also known as Cfi1) (Traverso et al., 2001; Visintin, Hwang 
and Amon, 1999; Shou et al., 1999). Net1 likely inhibits Cdc14 by occluding the active 
site of the phosphatase, acting as a highly specific competitive inhibitor in in vitro 
experiments (Traverso et al., 2001).  
 Net1 deletion causes slow cell growth, with delays in events throughout the cell cycle – 
notably bud formation, DNA replication, and mitotic entry. These delays are 
presumably due to Cdc14 being active towards interphase Cdk targets at this time 
(Visintin, Hwang and Amon, 1999). Indeed, whether or not net1Δ is actually viable has 
produced contradictory results, with this deletion having been identified as lethal in the 
S. cerevisiae S288C background in a genome-wide gene deletion screen (Giaever et al., 
2002). Cdc14 localisation can be de-regulated by using a CDC14TAB6-1 allele, which binds 
Net1 less strongly (Shou et al., 2001). Although, alone, this allele does not have a strong 
phenotype, it is lethal together with clb5Δ – cells to fail to complete DNA replication in 
this case (Bloom and Cross, 2007b). This is likely because the combination of lower 
than usual Cdk activity with higher than usual Cdk-opposing phosphatase activity does 
not allow for the timely phosphorylation of the Cdk substrates necessary for DNA 
replication. This indicates the importance of proper regulation of Cdc14 activity.   
Cdc14 is activated and released from the nucleolus after phosphorylation of Net1 by 
both Cdk and Polo kinase (Cdc5). Phosphorylation of Net1 leads to reduced affinity for 
Cdc14; in vitro, phosphorylated Net1 is no longer able to inhibit Cdc14 (Azzam et al., 
2004; Yoshida and Toh-e, 2002; Shou et al., 2002). Net1 phosphorylation, and therefore 
Cdc14 release, is prevented until early anaphase by the phosphatase PP2ACdc55, which 
keeps Net1 hypo-phosphorylated (Queralt, Lehane, Novak and Uhlmann, 2006). 
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In fact, release of Cdc14 from the nucleolus, achieved through the regulation of the 
phosphorylation state of Net1, occurs in two waves, depending on the actions of two 
successive signalling cascades, the FEAR (Cdc14 Early Anaphase Release) and MEN 
(Mitotic Exit Network) pathways. 
1.4.1 The FEAR pathway for Cdc14 release promotes early anaphase 
events 
Cdc14 release is initially activated by the actions of APCCdc20, and the degradation of 
securin. As such, once Esp1 (separase) has been released from Pds1 (securin), it has 
been shown to have a role other than that of cleaving cohesin; that of inhibiting 
PP2ACdc55(Queralt et al., 2006).  
The inhibition of PP2ACdc55 by Separase is brought about by the action of Separase and 
its interactor Slk19 upon the Cdc55 regulators Zds1 and Zds2, which regulate the 
localisation of Cdc55 in anaphase and prevent it from interacting with Net1(Queralt 
and Uhlmann, 2008; Rossio and Yoshida, 2011). Further, the proteins Fob1 and Spo12 
also contribute, together, to the activation of Cdc14 in early anaphase, although how 
they do so is not yet fully understood (Stegmeier, Visintin and Amon, 2002; Stegmeier 
et al., 2004). Along with Cdc5 and Clb-Cdk, all of the above proteins thus form a part of 
the FEAR pathway for Cdc14 release in early anaphase (Rock and Amon, 2009) (Fig.  
1.4).  
FEAR pathway released Cdc14 is predominantly restricted to the nucleus, and is 
necessary for coordinating a range of anaphase events in this cell cycle compartment. 
These range from promoting rDNA condensation and segregation, through controlling 
nuclear positioning, to spindle stabilisation and elongation, and positioning of the 
spindle midzone (D'amours, Stegmeier and Amon, 2004; Sullivan, Higuchi, Katis and 
Uhlmann, 2004; Mirchenko and Uhlmann, 2010; Higuchi and Uhlmann, 2005; Ross 
and Cohen-Fix, 2004; Wang, Yong-Gonzalez and Strunnikov, 2004; Woodbury and 
Morgan, 2007). The timely release of this phosphatase, synchronised with separase 
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activation, allows for the accurate coordination of chromosome segregation with the 
initiation of mitotic exit events.   
However, the FEAR pathway for Cdc14 is neither essential, nor enough to allow for the 
completion of mitotic exit. Absence of FEAR pathway components (barring separase, 
securin and PP2A, which have many other roles in the cell) is not lethal, and simply 
results in delayed Cdc14 release, and concomitantly delayed mitotic exit.  
1.4.2 The MEN pathway for Cdc14 release promotes late mitotic events 
and cytokinesis 
As such, a second signalling pathway is necessary for the sustained release of Cdc14 in 
late anaphase. Indeed, early Cdc14 release is promoted by Cdk phosphorylation of Net1. 
With APCCdh1 active in later anaphase, rapidly degrading the mitotic cyclins and thus 
causing a fast decline in Cdk activity, Net1 phosphorylation can no longer be 
maintained by the kinase.  
To maintain Cdc14 release after this point, declining Cdk activity and rising Cdc14 
activity result in the activation of the G-protein coupled signaling cascade known as the 
MEN, consisting of the GTPase Tem1, its regulators Lte1 and Bub2/ Bfa1, and its 
downstream kinases Cdc15 and Dbf2/Mob1 (Fig. 1.4) (Shou et al., 1999; Jaspersen, 
Charles, Tinker-Kulberg and Morgan, 1998) .  Cdc15 is dephosphorylated in mid-
anaphase by Cdc14, dephosphorylation that is thought to contribute to its activation 
(Jaspersen and Morgan, 2000). Similarly, Mob1 is phosphorylated and inhibited by Cdk 
and dephosphorylated and activated by Cdc14 (König, Maekawa and Schiebel, 2010). 
Thus Cdc14 activates its own sustained release.  Cdc5, the only Cdc14 regulator that is a 
member of both the FEAR and MEN, inhibits Bub2/Bfa1, themselves inhibitory 
regulators of Tem1 (Hu et al., 2001). MEN pathway released Cdc14 is necessary for the 
completion of mitosis and cytokinesis. Indeed, mutants for Tem1, Cdc15 or Dbf2 arrest 
in telophase with fully segregated chromosomes but long spindles (Shirayama, Matsui 
and Toh-E, 1994; Culotti and Hartwell, 1971; Toyn and Johnston, 1994; Sanchez-Diaz 
et al., 2012).  
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How the MEN is responsible for maintaining Net1’s phosphorylation despite declining 
Cdk activity is unclear, although it is likely that the MEN kinases Dbf2, Mob1 and 
Cdc15 have the potential to target Net1, as well as Cdc5. Moreover, how Cdc14 release 
is sustained while Cdk activity declines between anaphase onset and MEN activation 
has remained poorly understood.  
At the M/G1 transition, (through the actions of Cdc14 itself, as well as those of 
PP2ACdc55, whose inhibition ends) Net1 becomes dephosphorylated, which in turn 
promotes the re-sequestration of Cdc14, in time for the following cell cycle.  
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Figure 1.4 – The FEAR and MEN pathways cooperate to release Cdc14 in two waves  
An initial and transient wave of Cdc14 is released in early anaphase through the actions 
of FEAR pathway components, necessary for a coordinating a range of anaphase events. 
Sustained Cdc14 release occurs later in anaphase, through the actions of the MEN, and 
is necessary for the completion of mitotic exit and cytokinesis.  
 
 
 
 
 
 
 
 
FEAR pathway MEN pathway 
G1 - Early anaphase: 
Sequestered Cdc14 
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1.5 Cdc14 is required for rDNA condensation and segregation  
One of the main roles for FEAR pathway released Cdc14 is in promoting the timely and 
accurate segregation of the rDNA. 
1.5.1 The rDNA is the last region of the genome to segregate 
The rDNA is a unique region of the genome. It is composed of 150-200 identical 
repeats, each 9.1 kb in length, tandemly arrayed on the long arm of Chromosome XII, 
(making up around 70% of the long arm of the DNA on chromosome XII). Each rDNA 
repeat comprises two genes, the 35S rRNA gene (the product of which is later processed 
to generate mature 18S, 5.8S and 25S rRNA transcripts) and the 5S rRNA gene. Further, 
there are several cis elements within each repeat – two nontranscribed spacer regions 
(NTS1 and NTS2),  within which are situated, respectively, the origin of DNA 
replication (ARS), and the replication fork barrier (RFB) (Brewer and Fangman, 1988; 
Linskens and Huberman, 1988) (Fig. 1.5).  Together, the rDNA repeats and their 
associated proteins make up the complex macromolecular structure known as the 
nucleolus – a factory for the production of ribosomal RNA and a region important for 
cell cycle regulation through its sequestration of Cdc14.  
 
Figure 1.5 – Structure of the budding yeast rDNA repeats 
150 to 200 repeats of the rDNA are arrayed on the long arm of Chr XII. Within each 
repeat are the genes for the 35S and 5S rRNA precursors, an origin of replication (ARS) 
and a replication fork barrier (RFB), where replication terminates.  
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The rDNA is also unique in that its behaviour during the cell cycle is different to that of 
the rest of the chromosomes. As such, it has long been observed that the nucleolus is 
the last region of the genome to segregate (Granot and Snyder, 1991; Sullivan and 
Uhlmann, 2003). In contrast to the rest of the chromosomes, artificially induced 
cohesin cleavage (in a metaphase arrested state, in the absence of separase activity but 
in the presence of the externally expressed TEV protease) is not sufficient to allow the 
segregation of the rDNA (Sullivan et al., 2004). In fact, Cdc14 activity in early anaphase 
is required for the segregation of the rDNA; cdc14-ts mutants arrest in mid-anaphase 
with the bulk of the DNA segregated but not the rDNA. In contrast, cdc15-2 mutants, 
in which the MEN pathway, but not the FEAR pathway, is defective, show two distinct 
nucleolar masses, situated at opposite ends of the cell – correctly segregated rDNA 
{(D'amours, Stegmeier and Amon, 2004; Sullivan et al., 2004). Further, a requirement 
for the non-cohesin directed activity of separase in early anaphase – that of activating 
the FEAR pathway – has been shown (Sullivan et al., 2004).  
1.5.2 Cdc14 is required for Condensin recruitment to the rDNA 
One of the known requirements of Cdc14 for rDNA segregation is in fact the ability of 
this phosphatase to promote condensation of the rDNA. As such, the rDNA is less 
condensed in the absence of Cdc14 activity than it is in wild-type cells. Further, the 
rDNA locus, as well as segregating after the rest of the genome, only finishes 
compacting in late anaphase, again after the rest of the genome has already segregated – 
the former likely a consequence of the latter (Machin, 2005). Condensin is required for 
late compaction of the rDNA locus, with recruitment of condensin being impaired in 
Cdc14 mutants (Sullivan et al., 2004; D'amours, Stegmeier and Amon, 2004; Wang, 
Yong-Gonzalez and Strunnikov, 2004; Machin, 2005). Indeed, the majority of the 
Condensin in budding yeast mitosis localises to the rDNA, and Condensin mutants 
segregate the bulk of the chromosomes but not the nucleolus, reminiscent to that which 
occurs in Cdc14 mutants (Freeman, 2000). Condensin promotes decatenation of the 
rDNA locus as well as compacting it, probably through stimulating the activity of 
Topoisomerase II, further promoting its timely and accurate segregation (D'Ambrosio, 
Kelly, Shirahige and Uhlmann, 2008).  
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However, how Cdc14 activity and Condensin recruitment to the rDNA are linked is not 
yet fully clear. On the one hand, it seems logical that Condensin itself should be the 
Cdc14 target involved, with dephosphorylation controlling its recruitment to the rDNA. 
However, a direct link between Cdc14 and Condensin has yet to be confirmed. It has 
also been suggested that Cdc14 prevents transcription at the rDNA locus during 
anaphase by inhibiting RNA polymerase I, facilitating the access of Condensin to the 
locus (Clemente-Blanco et al., 2009). However, it has been previously and extensively 
shown that rDNA transcription does not vary in a cell cycle dependent manner. As 
such, the bulk of cellular rRNA increases exponentially during the cell cycle, and rRNA 
synthesis rates and r-protein synthesis rates per unit amount of RNA remain constant 
throughout all cell cycle stages (Elliott and McLaughlin, 1979; Elliott, Warner and 
McLaughlin, 1979; Elliott and McLaughlin, 1983).  
1.6  A role for phosphatases in the quantitative model for the 
cell cycle                                      
1.6.1 A quantitative model for mitotic exit  
Through the successive actions of the FEAR and MEN, a situation arises where Cdc14 
activity is gradually rising throughout anaphase, with Clb-Cdk activity concomitantly 
declining. From a qualitative point of view, however, the same phosphatase, with the 
same activity, is present in the cell in early anaphase and late anaphase, albeit at 
different levels. This has led people to ask how this same phosphatase can drive the 
ordered dephosphorylation of different substrates, and ensure that mitotic exit events 
happen in the correct order? Indeed, it seems logical that spindle elongation should 
occur before spindle disassembly, and that chromosome segregation happen before 
chromosome decondensation. How is this achieved?  
In examining how the timing of dephosphorylation by Cdc14 is controlled, Bouchoux 
and Uhlmann have recently proposed an answer to this question. They examined the 
catalytic efficiencies of “early” and “late” dephosphorylated substrates, for both Cdc14 
and Clb2-Cdk, by in vitro reconstitution of the system. There is, overall, little 
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correlation between the catalytic efficiencies of Clb2-Cdc28 for these substrates and 
their timing of dephosphorylation. Significantly, the opposite result was noted for 
Cdc14. Further, an even greater correlation was recorded between the ratios of catalytic 
efficiencies of phosphatase versus kinase. They were also able to conclude that the 
timing of dephosphorylation was not directly related to cyclin specificity  (i.e. 
substrates of S phase cyclins being dephosphorylated before those of M phase cyclins, 
for instance Orc6, a substrate for Clb5, is dephosphorylated late in mitotic exit) or 
number of phosphosites on the target protein (Bouchoux and Uhlmann, 2011).  
In fact, that the ratio of Cdc14 to Cdk activity should control timing of target substrate 
dephosphorylation during mitosis seems logical. As such, at any time in mitotic exit, 
substrates are subjected to both phosphorylation by Cdk and dephosphorylation by 
Cdc14. It is only when the activity of Cdc14 can “win” over that of Cdk, that the target 
protein can be dephosphorylated. How Cdc14 possesses higher affinity for certain 
substrates over others remains to be determined.  
In this way, a quantitative mechanism for control of ordered substrate 
dephosphorylation during mitotic exit is revealed, complementing Stern and Nurse’s 
quantitative model for the control of ordered substrate phosphorylation before and 
during mitotic entry (Fig. 1.6).  
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Figure 1.6 – A quantitative model for Cdk substrate dephosphorylation during 
mitotic exit  
Cdk substrates are dephosphorylated in an ordered manner depending on the ratio of 
Cdk to Cdc14 phosphatase activity during mitotic exit. During this time, Cdk activity is 
declining due to the actions of the APC, and Cdc14 activity is rising due to the 
successive actions of the FEAR and MEN pathways. From (Bouchoux and Uhlmann, 
2011).  
1.6.2 A quantitative role for phosphatases in interphase 
Going back to the quantitative model for the cell cycle, the evidence from mitotic exit 
can be applied to what is known so far about mitotic entry, and the ordering of S phase 
and M phase. Removing Cyclin specificity from the picture, we have a system where 
qualitatively the same kind of (or very similar) Cdk activity, although in quantitatively 
different amounts, is responsible for ordered phosphorylation of Cdk substrates during 
interphase. Two possibilities as to how this ordering is achieved are proposed. On the 
one hand, it could be that Cdk substrates have a wide range of affinities for Cdk 
(notwithstanding Cyclin Specificity), with the “best” substrates being phosphorylated in 
early interphase, with low Cdk activity, and the “worst” being phosphorylated in 
mitosis, when Cdk activity is highest. However, in a space as small and confined as a 
cell, where Cdk-Cyclin complexes and substrates are in close proximity (and with μM 
intracellular cyclin concentrations), given the high efficiency of phosphorylation and 
the speed of substrate turnover – even taking into account substrate competition – it 
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can be imagined that the worst substrates would be phosphorylated very shortly after 
the best substrates (Loog and Morgan, 2005; Ghaemmaghami et al., 2003). It is hard to 
envision how  “mitotic” substrate phosphorylation could thus be delayed until mitosis, 
or how checkpoints would be given adequate time to act. Cdk has an extremely wide 
range of catalytic efficiencies for substrates, which do not necessarily relate to the order 
of in vivo substrate phosphorylation during the cell cycle (Loog and Morgan, 2005). 
On the other hand, it could be that, as observed in mitotic exit, a balance of 
kinase/phosphatase activity is responsible for ordered phosphorylation (Fig. 1.7). As 
such, M-phase Cdk substrates would be good substrates for the phosphatase and bad 
for the kinase, and G1-phase Cdk substrates the opposite. Phosphatase activity would 
increase the time-resolution of substrate phosphorylation, and allow a built-in lag, or 
reaction time, for the cell to take action in the event of perturbations such as DNA 
damage, or SAC activation. Is there any evidence for to support such a model? What 
could the identity of such a phosphatase be? 
 
Figure 1.7 – Cdk-opposing phosphatase activity in the quantitative model for the cell 
cycle 
Cdk-opposing phosphatase activity may complement Cdk activity in the quantitative 
model for the cell cycle, allowing for the ordered phosphorylation of Cdk substrates in 
interphase and ordered dephosphorylation of Cdk substrates during mitotic exit.  
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1.7 Serine/Threonine phosphatases in the S. cerevisiae cell 
cycle 
Several Cdk-opposing phosphatases other than Cdc14 are active in the budding yeast 
cell cycle, and are candidates for opposing Cdk activity in interphase.  
1.7.1 PP2A plays a variety of roles in the cell cycle 
PP2A is probably the best-known Cdk-opposing phosphatase, other than Cdc14, in 
budding yeast.  PP2A is a multi-subunit holoenzyme composed of a scaffold subunit, 
known as Tpd3, a catalytic subunit, provided interchangeably by the proteins Pph21 or 
Pph22, and one of three regulatory subunits: Cdc55, Rts1 or Rts3. Regulatory subunits 
provide PP2A with substrate specificity, with PP2ACdc55 and PP2ARts1 having distinct 
roles in the cell cycle (Jiang, 2006). The role of Rts3 is unknown. As mentioned 
previously, PP2ACdc55 maintains Net1 in a hypo-phosphorylated state until the onset of 
anaphase, thus preventing too early entry into anaphase. This phosphatase also has 
several other cell cycle roles.   
1.7.1.1 PP2ACdc55 promotes mitotic entry 
It has become apparent that PP2ACdc55 plays an important role in controlling the G2/M 
transition by modulating the levels of inhibitory Y19 phosphorylation on Cdk. In 
budding yeast, cells lacking Cdc55 are viable (although cold-sensitive) but have altered 
cell cycle progression, are morphologically abnormal and have a slow growth rate. 
These bulk of these defects can be rescued by mutation of Y19 on Cdk to a non-
phosphorylatable F (Cdc28F19)(Wang and Burke, 1997). Y19 phosphorylation of Cdk1 
is in fact carried out by Swe1 (=Wee1), one of the main negative regulators of mitotic 
entry – PP2ACdc55 has been shown to directly oppose phosphorylation and activation of 
Swe1 during interphase (Harvey et al., 2011; Lin and Arndt, 1995). In fact, deletion of 
Swe1 mimics Cdc28F19 in restoring comparatively normal cell cycle progression to 
Cdc55 mutants. A double deletion strain (swe1Δ cdc55Δ) can thus be used to study the 
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role of Cdc55 in interphase independently of its role in modulating Y19 
phosphorylation. 
Y19 phosphorylation of Cyclin-Cdk by Swe1 specifically inhibits mitotic Cyclin-Cdk 
complexes, most strongly reducing the activity of Clb2-Cdk, and also that of Clb3/4-
Cdk, but having little effect upon G1 or S phase Cyclin-Cdk complexes. Inhibitory 
phosphorylation of Y19 (and the timing of its removal) is a major determinant of the 
timing of mitotic entry. This mechanism of Cdk inhibition is highly conserved; in fact 
phosphorylation of Y15 on Cdk1 homologs plays a bigger role in mitotic progression in 
other organisms (including the fission yeast S. pombe) than it does in budding yeast. 
PP2ACdc55 has also been postulated to be a regulator of Mih1 (=Cdc25) by 
dephosphorylating it, although whether this dephosphorylation is activatory or 
inhibitory remains unclear (Pal, Paraz and Kellogg, 2008).  
 The targets and actions of the homologs of PP2ACdc55  (PP2A-B55) in mitotic entry are 
conserved, however in most other organisms dephosphorylation of Wee1 by PP2A-B55 
is activatory rather than inhibitory. Further PP2A-B55 is known to inhibit Cdc25. 
Therefore PP2A opposes, rather than promotes, mitotic entry in other organisms – the 
phosphatase is acting upon the same targets, however with opposite effects (Tuck, 
Zhang, Potapova and Malumbres, 2013; Kinoshita et al., 1993) (Fig. 1.8). 
 
Figure 1.8 – PP2ACdc55 inhibits Swe1 at the G2/M transition in budding yeast 
PP2ACdc55 plays a role in mitotic entry through the regulation of the phosphorylation 
state of Cdk-Y19. PP2ACdc55 dephosphorylates and inhibits Swe1, allowing the 
generation of a low level of Cdk activity in early mitosis.  
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By inhibiting Swe1 phosphorylation, PP2ACdc55 is a component of the quantitative, 
“Cdk threshold”, model for mitotic progression (Oikonomou and Cross, 2011). It is 
required for the generation of a stable and low-level plateau of Clb2-Cdc28 activity in 
early mitosis. In fact, the activating phosphorylation events on Swe1 are themselves 
carried out by Cdc28-Clb2, an example of the kinase inhibiting its own activation, 
generating a negative feedback loop (Fig. 1.8). In order to generate a dynamic steady 
state in which a stable low level of Cdc28-Clb2 activity can be maintained, despite the 
presence of its inhibitor Swe1, and with rising levels of Clb2, PP2ACdc55 opposes Cdk 
phosphorylation of Swe1. When Clb2 levels reach a certain threshold, Cdk activity can 
overcome the inhibition from Swe1, and PP2ACdc55 becomes inhibited by the actions of 
the FEAR pathway, causing further phosphorylation of Swe1, with 
hyperphosphorylation being inhibitory, rather than activating, for the protein (Harvey 
et al., 2011). This results in a dramatic switch from a stable steady state of low Cdk 
activity to a stable steady state of high Cdk activity, making the transition between these 
two states irreversible and abrupt. This is another example of a kinase/phosphatase 
ratio influencing the timing of cell cycle events in a quantitative manner. Interestingly, 
the Cdk threshold model in mammalian systems also works through Wee1, with initial 
Wee1 phosphorylation activating the protein, and further phosphorylation inhibiting it, 
depending on levels of Cdk activity (Deibler and Kirschner, 2010). 
1.7.1.2 PP2ACdc55 inhibits anaphase onset 
In a normal cell cycle, Swe1 is degraded shortly after mitotic entry, in order for full Cdk 
activation to occur. However, when the actin cytoskeleton is perturbed, Swe1 is 
stabilised and Cdk activity remains inhibited in response to a morphological 
checkpoint (Lew and Reed, 1995; Sia, 1998). In this case, the cell cycle is arrested in 
early metaphase, after spindle formation, with high securin levels and no sister 
chromatid separation. Given the function of PP2ACdc55 in inhibiting Swe1, it seems 
likely that PP2ACdc55 would be needed for exiting this morphogenesis checkpoint by 
promoting the downregulation of Swe1. However, it was found that this is not the case. 
Indeed, the opposite is true; PP2ACdc55 is required for maintenance of the 
morphogenesis checkpoint. Inactivation of PP2ACdc55 is sufficient to promote sister 
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chromatid separation despite the presence of an active checkpoint. In fact, cells lacking 
PP2ACdc55 are also defective in maintenance of the spindle checkpoint, which has been 
put down to early Cdc14 release in these cells. However, no premature Cdc14 release 
was seen upon bypass of the morphogenetic checkpoint (Chiroli, Rossio, Lucchini and 
Piatti, 2007).  
This points to PP2ACdc55 as a more general inhibitor of anaphase onset. It has been 
suggested that PP2ACdc55 inhibits Separase before activation of the APC, under 
conditions where the sister chromatids are not under tension, to prevent premature 
chromosome segregation. This adds yet another level of control to the metaphase-
anaphase transition (Clift, Bizzari and Marston, 2009).  
1.7.1.3 PP2ARts1 is required for the G1/S transition and regulation of cell 
size 
Less is known about the roles of PP2A in complex with its other regulatory subunit, 
Rts1. However, it has been established that PP2ARts1 activity promotes the transcription 
of the G1 cyclins Cln1 and Cln2, possibly through regulation of Swi6. Rts1 deletion is 
lethal when combined with deletion of Cln1 and Cln2, and alone causes slow growth, a 
delay in bud emergence and low levels of G1 cyclin transcripts. rts1Δ cells are 
abnormally large, and are unable to alter cell size in response to nutrient availability, 
indicating that PP2ARts1 is required for nutrient modulation of cell size (Artiles, 
Anastasia, McCusker and Kellogg, 2009). It is possible that this phosphatase is also 
required for nutrient modulation of cell size in mitosis via regulation of Swe1.  
1.7.2 PP1 is essential for cell cycle progression 
The final serine/threonine phosphatase in budding yeast – PP1 – is a holoenzyme made 
up of a core catalytic subunit, the protein Glc7, and a regulatory subunit, of which there 
are more than 30 (reviewed in (Cannon, 2010)). Glc7 was first identified as being 
important for glycogen metabolism, but PP1 has since been shown to have a large 
variety of roles in S. cerevisiae. Notably, PP1 is essential for cell cycle progression, with 
PP1 depletion causing a metaphase arrest (Stark, 1996).  
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1.7.2.1 PP1 promotes correct kinetochore-microtubule interactions 
Kinetochores need to be properly attached to microtubules for correct chromosome 
biorientation and chromosome segregation. As such, PP1 antagonises Ipl1 (Aurora) 
phosphorylation events at the kinetochore, with absence of PP1 causing activation of 
the spindle checkpoint and halting mitotic progression (Bloecher and Tatchell, 1999). 
PP1 is targeted to the kinetochore through an interaction with its regulatory subunit 
and target protein Fin1, where it dephosphorylates Ndc10 and Dam1, promoting 
mitotic spindle attachment to the kinetochore (Akiyoshi, Nelson, Ranish and Biggins, 
2009; Cheeseman et al., 2002; Sassoon et al., 1999).  
1.7.2.2 PP1 reverses cell cycle checkpoints 
Not only does PP1 play a role in promoting correct spindle-microtubule attachments, 
and thus the satisfaction of the spindle assembly checkpoint, but it is also thought to 
directly silence this checkpoint. Glc7 overexpression allows progression into anaphase 
even when the spindle checkpoint is defective. Further, Glc7 is required for exit from a 
transient spindle checkpoint arrest – in the absence of Glc7, cells were unable to escape 
from a spindle checkpoint arrest caused by addition of the spindle depolymerising drug 
nocodazole, even after removal of the drug. It is thought that PP1 reverses both Ipl1 
and Mps1 (major spindle checkpoint kinases) phosphorylation to actively promote 
silencing of this checkpoint (Pinsky, Nelson and Biggins, 2009). PP1 is also involved in 
recovery from inhibition of DNA replication (and activation of the DNA damage 
checkpoint) (Bazzi et al., 2010). 
From looking at the role of Cdk-opposing phosphatases in S. cerevisiae, it seems that 
any or none of these three phosphatases could have role in directly opposing Cdk 
phosphorylation in interphase. What does the evidence from other organisms tell us? 
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1.8 Serine/Threonine phosphatases in other organisms 
1.8.1 The functions of Cdc14 are highly divergent in different organisms 
The Cdc14 family of phosphatases is highly conserved, with orthologs having been 
identified in a wide range of organisms. Cdc14 orthologs have a bipartite structure, 
with a conserved N-terminal core region, providing catalytic activity, and a non-
conserved C-terminal region of variable length. The crystal structure of the N-terminal 
region of human Cdc14B has revealed two structurally similar domains, arranged in 
tandem, using which it is possible to create a homology model of budding yeast Cdc14 
(Gray, Good, Tonks and Barford, 2003; Mocciaro and Schiebel, 2010) (Fig 1.9). Despite 
the structural similarities between orthologs, budding yeast Cdc14 (ScCdc14) is the 
only organism in which Cdc14 activity is a confirmed requirement for mitotic exit.  
1.8.1.1 Roles of Clp1, the S. pombe Cdc14 ortholog 
In S.pombe, Clp1, the Cdc14 ortholog, behaves in a manner similar to ScCdc14 during 
interphase, when it is sequestered in the nucleolus. However, it is released at the G2/M 
transition rather than in anaphase, release that is not dependent on the FEAR pathway 
(Fig 1.10).. During mitosis, Clp1 dephosphorylates a number of Cdk substrates and 
regulates spindle stability and chromosome biorientation. Its main role, however, is in 
cytokinesis, where it regulates the formation of the septum, although it is not essential 
(Fig 1.10). Its subcellular localisation, and concomitantly, its role in cytokinesis, is 
regulated by the SIN pathway (homologous to the MEN pathway in budding 
yeast)(Trautmann et al., 2001; Buttrick et al., 2011).  
1.8.1.2 Roles of metazoan Cdc14 orthologs 
In metazoans, the roles of Cdc14 are even more divergent, although relatively little is 
known about the function of Cdc14 in these organisms. In both C. elegans and X. leavis, 
Cdc14 may be important for the completion of cytokinesis.  In G. gallus, on the other 
hand, which has two Cdc14 isoforms (A and B), no mitotic role for Cdc14 has yet been 
Chapter 1 Introduction 
 46 
found, although both isoforms might be involved in DNA repair pathways (Fig. 1.10) 
(Mocciaro and Schiebel, 2010).  
In mammalian cells, Cdc14 has three isoforms, A, B and C. Despite being the focus for 
many studies, the molecular functions of the Cdc14 orthologs in mammalian cells, and 
whether they have a role in cell cycle progression and mitotic exit, remain unclear. 
siRNAi against Cdc14A has revealed a role in the regulation of the centrosome cycle, 
with cells consequently having defects in centrosome separation as well as in mitosis 
and cytokinesis. Depending on study and experiments used (RNAi 
depletion/overexpression), human Cdc14B has been suggested to have a role in mitotic 
spindle assembly, DNA damage checkpoint inactivation, centriole duplication and 
mitotic exit (Fig. 1.10). However, using gene knockout studies in human cell lines, it 
has been demonstrated that neither Cdc14A or B are essential for cell viability, and 
indeed no defects in mitotic progression or centrosome duplication were found in 
either case. Thus the function of Cdc14 in mammalian systems remains controversial.  
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Figure 1.9 – The structure of Cdc14 orthologs is conserved 
A. Cdc14 orthologs have a conserved N-terminal core (red) and a variable C terminal 
domain (blue). The conserved PTP motif (yellow) forms the catalytic site. S.cerevisiae 
(ScCdc14) S. pombe (Clp1), C. elegans (CeCdc14), X. Leavis (XCdc14A), G. gallus 
(cCdc14A/B) and human (hCdc14A/B) are aligned. Adapted from (Mocciaro and 
Schiebel, 2010) B. Homology model of ScCdc14 conserved domain, based on the 
structure of the human Cdc14B N-terminal core. In bright red is Domain A, and in 
dark red Domain B, which provides catalytic activity and contains the PTP motif. 
Model was made using PyMOL (pymol.org).    
A 
B 
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Figure 1.10 – Cdc14 orthologs have divergent functions  
The roles of S.pombe (Clp1), C. elegans (CeCdc14), X. Leavis (XCdc14A), G. gallus 
(cCdc14A/B) and human (hCdc14A/B) are shown. Cdc14 localisation during 
interphase and mitosis is depicted in shades of red. Adapted from (Mocciaro and 
Schiebel, 2010). 
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1.8.2 Mitotic exit requires phosphatase activity in all eukaryotes 
Despite the fact that Cdc14 activity is not a requirement for mitotic exit in other 
organisms, it is likely that a quantitative mechanism for ordered substrate 
dephosphorylation during mitotic exit is also applicable in eukaryotes other than 
budding yeast. Indeed, Cdk substrate dephosphorylation seems to be a requirement for 
mitotic exit, as persistent Cdk activity prevents return to G1 in organisms as diverse as 
S. pombe, Xenopus and Drosophila, and protein phosphatase activity is a general 
requirement for progression through mitosis (Parry and O'Farrell, 2001; Murray, 
Solomon and Kirschner, 1989; Yamano, Gannon and Hunt, 1996; Chen et al., 2007).  
In mammalian cells, application of a variety of Cdk inhibitors (including RO-3306, 
GCP-74514A, flavopiridol, BMI-1026, roscovitine or purvalanol A) has been shown to 
induce mitotic exit – although not always with very high efficiency – presumably due to 
the ensuing dramatic drop in Cdk activity (Skoufias et al., 2007; Potapova et al., 2006; 
Manchado et al., 2010; Niiya et al., 2005). However, in one study, where roscovitine was 
applied to cells in combination with the drug MG132 (inhibiting proteasomal 
degradation), mitotic exit no longer occurred, indicating that this drop in Cdk activity 
is not sufficient to cause a return to G1 (Skoufias et al., 2007). Similarly, adding 
inhibitors of PP1/PP2A phosphatases (Okadaic acid – OA) together with roscovitine 
blocks mitotic exit from occurring, with cells arresting in mitosis with condensed 
chromosomes and high levels of Cdk phosphorylation (Skoufias et al., 2007; Manchado 
et al., 2010). Hyper-activation of PP2A, along with the application of roscovitine, leads 
to a semblance of mitotic exit in Mouse Embryonic Fibroblasts (MEFs) lacking Cdc20 
and Securin, with Cdk substrates being dephosphorylated and the DNA decondensed, 
exit prevented by addition of OA. These double mutant cells are usually arrested in 
metaphase, an arrest that cannot be rescued by the application of roscovitine alone. 
Hyper-activation of PP1 also leads to partial dephosphorylation of Cdk substrates in 
Cdc20-null cells in the presence of roscovitine (Manchado et al., 2010).  
Together, these results indicate that one or several phosphatases likely need to be 
activated after destruction of Cyclin B by the APC for mitotic exit to occur, as is the 
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case in budding yeast, where Cdc14 is activated by APCCdc20 degradation of Securin. 
Securin itself as the necessary APC target was ruled out in these studies, as was Separase 
(Skoufias et al., 2007; Manchado et al., 2010).  
It has also been shown that depletion of PP2A-B55δ in Xenopus egg extracts in 
interphase prevented them from exiting mitosis (Mochida, Ikeo, Gannon and Hunt, 
2009). Studies aiming to elucidate the identity of the phosphatase necessary for mitotic 
exit and cytokinesis in mammalian systems have identified PP1 (Wu et al., 2009; 
Manchado et al., 2010), the Ca(2+)- and calmodulin-dependent phosphatase, 
Calcineurin (CaN)(Chircop et al., 2010), Fcp1 (Visconti, Palazzo, Monica and Grieco, 
2012), PP2A (Schmitz et al., 2010; Garriga et al., 2004; Manchado et al., 2010), as well as 
Cdc14B (Tumurbaatar et al., 2011). Pocket protein dephosphorylation (the pocket 
proteins being pRB, p107 and p130) during mitosis has indeed been shown to depend, 
in a quantitative manner, on the ratio of Cdk/PP2A (or PP2A-like) activity (Garriga et 
al., 2004). 
It seems highly likely that a range of phosphatases cooperate to dephosphorylate Cdk 
targets and bring about mitotic exit in higher eukaryotes, varying between organisms or 
even between cell types or developmental stages within the same organism. That this 
occurs in a quantitative manner is also probable. For instance, it has been established 
that the activity levels of PP2A-B55δ are stringently regulated by the actions of the 
mitotic kinase Greatwall, ensuring that the correct balance of kinase to phosphatase 
activity (high kinase, low phosphatase) is maintained for mitotic phosphorylation to 
occur. Indeed, Greatwall is required for maintenance of mitosis and its depletion causes 
mitotic exit to occur in X. leavis egg extracts, indicating that the ratio of 
kinase/phosphatase is the key determinant for mitotic exit (Vigneron et al., 2009). 
1.8.3 A role for PP2A in interphase 
It is also likely that one or several of these phosphatases should play a role in opposing 
Cdk phosphorylation events in interphase. In the study by Garriga et al, it was 
demonstrated that pocket proteins became abruptly dephosphorylated upon Cdk 
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inhibition, whatever cell cycle stage this inhibition was carried out at, strongly 
indicating that Cdk phosphorylation of these proteins is being opposed throughout the 
cell cycle, even in interphase (Garriga et al., 2004).  
Indeed, in X. leavis, PP2A-B55δ has a role in interphase as well as mitotic exit. 
Immunodepletion of this phosphatase in interphase egg extracts causes early entry into 
mitosis, and its inhibition triggers mitotic entry even with very low levels of Cyclin-Cdk 
activity (Krasinska et al., 2011; Mochida et al., 2009). Indeed, PP2A downregulation (by 
Greatwall) is necessary for mitotic entry as well as mitotic exit in this organism 
(Castilho et al., 2009; Vigneron et al., 2009). Mathematical modelling indicates that 
PP2A activity is necessary for S phase and mitosis to be mutually exclusive states, and 
to promote dynamic transitions between these two states (Krasinska et al., 2011). 
Further, increasing the levels of recombinant PP2A-B55δ in egg extracts leads to a 
dose-dependent delay in mitotic progression (Mochida et al., 2009). Therefore the 
timing of interphase events, and the ordering of S phase and mitosis in X. leavis, is 
determined by a balance between opposing kinase and phosphatase activities in a 
quantitative manner (Fisher, Krasinska, Coudreuse and Novak, 2012).  It is possible 
that this might be due to an effect upon the Wee1-Cdc25 loop, as noted in budding 
yeast. However, it is also possible that this is more direct – high PP2A levels in 
interphase acting as a “buffer” to prevent early mitotic entry through phosphorylation 
of Cdk1 targets. 
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1.9 Aims and outline of this thesis 
Our knowledge of cell cycle regulation by phosphatases has been increasing over the 
past decades.  However, much remains to be elucidated, both in the well-characterized 
process that is mitotic exit, and regarding the role of Cdk-opposing phosphatases in 
other cell cycle stages. In this thesis, I hope to present new insights into both of these 
aspects of cell cycle regulation, using S. cerevisiae as a model organism. In particular, I 
have focused on answering two questions.  
1.9.1 What are the Cdc14 targets necessary for rDNA condensation and 
or/segregation in early anaphase?  
As discussed extensively in this chapter, the role of Cdc14 in budding yeast mitotic exit, 
and the regulation of the activity of this phosphatase, are relatively well understood. In 
particular, it is well established that Cdc14 functions to promote the condensation 
and/or segregation of the rDNA repeats in early to mid-anaphase. However, the exact 
targets upon which Cdc14 is acting to promote these processes remain unclear. 
Therefore, my initial aim was to identify whether any such targets exist, and if so, how 
Cdc14 is regulating them in order to bring about these morphological changes within 
the nucleolus. Ultimately, I was unsuccessful in identifying any such targets, however 
my research led me to uncover a novel mechanism for the regulation of Cdc14 activity 
during anaphase. My results shall be presented and discussed in Chapter 3.  
1.9.2 Do Cdk-opposing phosphatases play a role in determining the 
timing of progression through interphase and entry into mitosis? 
In a second time, and after having focused on furthering our understanding of the role 
of mitotic phosphatases in mitotic exit, I next concentrated on the regulation of 
interphase by these phosphatases. As such, evidence from budding yeast mitotic exit 
and mitotic progression, as well as from X. leavis egg extracts, indicates that Cdk-
opposing phosphatases may be a necessary part of a quantitative model for the cell cycle. 
In this model, the ratio of kinase/phosphatase activity determines the ordered 
phosphorylation and dephosphorylation of mitotic phosphoproteins. This has been 
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demonstrated to be the case in budding yeast mitotic exit; whether it is also important 
for the ordering of S phase events and mitotic entry is what I have aimed to determine. 
I have seen that the phosphatase PP2ACdc55 may play a role in controlling the timing of 
Cdk substrate phosphorylation during interphase, which shall be the topic of Chapter 4.  
Finally, in Chapter 5, I shall discuss, more generally, the implications of my findings in 
deepening our current understanding of cell cycle regulation.   
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Chapter 2. Materials & Methods 
2.1 Yeast techniques 
2.1.1 Yeast strains and growth conditions 
All budding yeast strains used in this study were of W303 background (Table 2.2) apart 
from strains 2369, 4839 and 4848, which were of the S288C background. Cells were 
grown in YP (Yeast Peptone) supplemented with 2% w/v glucose (YPD – Yeast Peptone 
Dextrose) or 2% w/v raffinose/galactose (YP-Raff/Gal) (Table 2.1). For SILAC 
experiments, cells were grown in synthetic YNB media (Table 2.2) and 60 μg/ml of each 
of the following amino acids: tyrosine, uracil, tryptophan, leucine, adenine, histidine, 
isoleucine and phenylanine, and 50 μg/ml threonine, as well as 100 µg/ml of either 
heavy (13C), or light (12C), lysine or arginine, supplemented with 2% w/v glucose. For 
the selection of transformants, YNB agar plates were used lacking the auxotrophic 
amino acid used for selection. For selection based on Kanamycin resistance YPD agar 
plates were supplemented with the kanamycin derivative Geneticin G418 (50 μg/ml). 
Cells were sporulated on sporulation media. Strains harboring conditional Clb2-fusion 
cassettes were grown on medium lacking uracil to maintain the selectable marker and 
to prevent spontaneous recombination. Marker loop-out was then induced by β-
estradiol-dependent activation of Cre recombinase fused to an estradiol binding 
domain (Cre-EBD78), by addition of 1 mM β-estradiol to the growth medium. 
Medium name/ 
Abbreviation Composition 
YP 
Yeast Peptone –  1.1% w/v yeast extract, 2.2% w/v bacto-peptone 
and 0.0055% w/v adenine-HC 
YNB Yeast Nitrogen Base –  0.8% w/v yeast nitrogen base 
YP agar 
1.1% w/v yeast extract, 2.2% w/v bacto-peptone and 0.0055% w/v 
adenine-HC, 2% w/v agar 
YNB agar 0.8% w/v yeast nitrogen base, 2% w/v agar 
Sporulation 
media 
100 mM CH3COONa, 20 mM NaCl, 25 mM KCl, 1.5mM MgSO4 
and 1.5% w/v agar 
 
Table 2.1 –  Media composition  
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2.1.2 Strain List 
Strain number - Lab 
collection/personal 
collection (MG..) 
Description Mating type 
141 W303 a 
4652 Nur1-PK3::TRP a 
4653 Nur1-PK3::TRP cdc14-1 a 
4565 trp1::TRP1-CRE-EBD78 a 
4654 Nur1-Clb2::URA trp1::TRP1-CRE-EBD78 a 
4655 
Nur1-Clb2ΔCDK::URA trp1::TRP1-CRE-
EBD78 a 
4656 W303R (RDN1::ADE2 Rad5) a 
4657 W303R trp1::TRP1-CRE-EBD78 a 
4658 
W303R trp1::TRP1-CRE-EBD78 Nur1-
Clb2::URA a 
4659 
W303R trp1::TRP1-CRE-EBD78 Nur1-
Clb2ΔCDK::URA a 
4660 
Nur1-Clb2::URA Net1-YFP::HIS trp1::TRP1-
CRE-EBD78 a 
4661 
Nur1-Clb2ΔCDK::URA  Net1-YFP::HIS 
trp1::TRP1-CRE-EBD78 a 
4662 
Nur1-Clb2::URA Cdc14-GFP::LEU 
trp1::TRP1-CRE-EBD78 a 
4663 
Nur1-Clb2ΔCDK::URA  Cdc14-GFP::LEU 
trp1::TRP1-CRE-EBD78 a 
4664 nur1Δ::LEU a 
4665 nur1(9A)::LEU a 
4666 nur1Δ::LEU Cdc14-GFP::TRP  a 
4667 nur1(9A)::LEU Cdc14-GFP::TRP a 
4668 nur1Δ::LEU Cdc14-GFP::TRP Δspo12::HIS a 
4669 nur1(9A)::LEU Cdc14-GFP::TRP Δspo12::HIS a 
4670 spo12Δ::HIS Cdc14-GFP::TRP a 
4671 Cdc14-GFP::TRP a 
4672 Nur1(9A)-Clb2::URA trp1::TRP1-CRE-EBD78 a 
4673 
Nur1(9A)Clb2ΔCDK::URA trp1::TRP1-CRE-
EBD78 a 
4675 
Nur1-Clb2::URA trp1::TRP1-CRE-EBD78 
TAB6-1 Cdc14-PK3::LEU a 
4676 
Nur1-Clb2ΔCDK::URA trp1::TRP1-CRE-
EBD78 TAB6-1 Cdc14-PK3::LEU a 
844 dbf2-2 α 
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145 cdc15-2 a 
4677 nur1Δ::LEU dbf2-2 α 
4678 nur1Δ::LEU cdc15-2 a 
4679 
Net-myc9::TRP Cdc14-HA6::HIS Nur1-
PK3::LEU a 
4873 swe1Δ::HIS a 
4874 swe1Δ:HIS cdc55Δ::LEU a 
MG21 swe1Δ::HIS Ndd1-HA3::TRP a 
MG14 swe1Δ:HIS cdc55Δ::LEU Ndd1-HA3::TRP a 
MG73 swe1Δ::HIS Sli15-HA3::TRP a 
MG74 swe1Δ:HIS cdc55Δ::LEU Sli15-HA3::TRP a 
MG124 swe1Δ::HIS Acm1-HA3::TRP a 
MG125 swe1Δ:HIS cdc55Δ::LEU Acm1-HA3::TRP a 
2369 arg4Δ:KANMX4 lys1Δ::KANMX4 a 
4839 arg4Δ:KANMX4 lys1Δ::KANMX4 swe1Δ::HIS a 
4848 
arg4Δ:KANMX4 lys1Δ::KANMX4 swe1Δ:HIS 
cdc55Δ::LEUs a 
MG128 cdc28-as1 swe1Δ::HIS  a 
MG129 cdc28-as1 swe1Δ::HIS cdc55Δ::LEU a 
1262 cdc14-1 a 
 
Table 2.2 – Strain list 
2.1.3 Cell synchronization 
Budding yeast cells of the “a” mating type were arrested in G1 with the mating 
pheromone α-factor. To arrest cells, early log phase cultures (OD600 = 0.15) were 
treated with α-factor (provided by Peptide Synthesis Laboratory, Crick Institute 
Lincoln’s Inn Fields Laboratory) at a concentration of 2.5 μg/ml. The same amount of 
α-factor was added to cultures every 50 minutes during two hours and 30 minutes. 
Arrest was determined cytologically by the appearance of a pear-shaped “schmoos” and 
by FACS (Fluorescence-activated cell sorting) analysis of DNA content. G1 arrested 
cells were released by filtration with media devoid of α-factor and sugar. For filtration, 
cells were collected on a membrane filter using filtration apparatuses of different sizes 
depending on culture volume. Cells were washed with YP or YNB (>6 times culture 
volume) and released into YP or YNB media supplemented with the appropriate source 
of sugar and appropriate amino acids. For temperature sensitive strains cells were 
shifted to restrictive temperature at the time of release. For re-arrest in the following 
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G1, 3 times the initial concentration of α-factor was used if cells were released at 25°C, 
and 6 times the initial concentration of α-factor for cells released at temperatures > 
35.5°C. 
2.1.4 Yeast transformation 
Yeast transformation was performed using purified PCR products for epitope-tagging 
or gene disruption, or with linearised plasmid DNA for integration of promoter-gene 
cassettes or exchange of endogenous promoters of essential genes.  
About 50 ml of a mid-log-phase culture (OD 0.2-0.5) was pelleted at 3,000 rpm for 5 
minutes. The cell pellet was washed with 1 ml of distilled water and then with 1 ml TEL 
(10 mM Tris/HCl pH 7.5, 100 mM EDTA and 100 mM Lithium acetate) before being 
resuspended in 100 μ l TEL. 1 μg of either linearised vector DNA or PCR product was 
mixed with 2 μ l of 10 mg/ml single stranded salmon sperm carrier DNA and 300 μ l 
TELP (TEL plus 40% PEG 3350 or 4000). The cell suspension was added to this mix 
followed by a short vortex. After incubation at 25°C for 2-4 hours, cells were heat 
shocked at 42°C for 15 minutes. They were then pelleted at 6,000 rpm for 2 minutes, 
washed in 1 ml sorbitol and plated on selective media. Transformants were checked for 
the correct integration of the PCR cassette by PCR or Western blot analysis.  
2.1.5 Yeast mating and tetrad dissection 
Mating was induced by incubation of opposite mating type yeast strains on YPD plates 
at 25°C for 12 hours. Diploids were selected on appropriate selective media and grown 
on YPD for 24 hours. To induce sporulation, diploids were streaked on a sporulation 
plate for 2-3 days. Spores were then resuspended in 1 M sorbitol and treated with 
Lyticase (Sigma-Aldrich) at 30°C for 10 minutes to break the asci. The four released 
spores from each ascus were dissected using a Singer-MSM micromanipulator and 
incubated at 25°C until colony formation. 
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2.2 Biochemistry 
2.2.1 Preparation of protein extracts 
Protein extracts were prepared by precipitation with trichloroacetic acid (TCA), 
washed with 1 M Tris-base and resuspended in 100 μl 2xSDS buffer (100 mM Tris-HCl 
pH 6.8, 200 mM DTT, 4% SDS, 0.1% Bromophenol blue, 20% glycerol). 200 μl of 0.5 
mm glass beads (Biospec Products, Inc) were added and cells were lysed using a 
FastPrep at 5.5 m/s for 1 minute. Extracts were then spun down to separate them from 
the glass beads. Collected supernatant was boiled at 95°C for 2 minutes and cleared by 
briefly centrifuging at 13,000 rpm. 
2.2.2 SDS-polyacrylamide gel electrophoresis (Page) and Western 
blotting 
Protein samples were resolved on acrylamide/bis-acrylamide gels (37.5:1, 30% 
solution), with 375 mM Tris-HCl pH 8.8 and 0.1% SDS. Concentrations of acrylamide 
between 7% and 12% were used, depending on protein size. Proteins were migrated at 
50 mA using SDS-PAGE running buffer (25 mM Tris, 250 mM glycine and 0.1% SDS) 
in electrophoresis tanks from CBS scientific, CA. For Phos-Tag acrylamide gels, 100 µm 
MnCl2 and 50 µM Phos-tag (from 5 mM stock in methanol, Wako Chemicals), were 
added.  A broad range pre-stained protein marker (New England Biolabs) was added to 
determine protein migration, (although not to Phos-Tag acrylamide gels).  
Separated proteins were transferred onto pre-equilibrated nitrocellulose membranes 
using a wet-transfer tank (Biorad). Transfer buffer contained 3.03 g/l Tris base, 14.1 g/l 
glycine, 0.05% SDS and 20% v/v methanol, and was carried out either at 250 mA for 12 
hours or 400 mA for 2 hours. In the case of Phos-Tag acrylamide gels, gels were 
incubated in transfer buffer with 10 mM EDTA for 2 x 10 minutes and in transfer 
buffer alone for 1 x 10 minutes before transfer to eliminate the Mn2+ ions from the gel.  
The membrane was blocked with a 4% skimmed milk solution (Marvel) in PBST 
(Phosphate Buffered Saline Tween) (170 mM NaCl, 3 mM KCl, 10 mM Na2HPO4, 2 
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mMKH2PO4, 0.01% tween 20) for 30 minutes - 1 hour at room temperature. 
Membranes were then incubated with primary antibodies diluted in PBST containing 
4% milk for 1-2 hours at room temperature or at 4°C overnight. Antibodies used for 
Western detection are detailed in Table 2.2. : α -Clb2 (Santa Cruz, sc9071), α-Orc6 
(clone SB49); α-Sic1 (Santa Cruz, sc50441), α-Tub1 (clone YOL1/34, AbD Serotec), α-
Tat1 (Sigma-Aldrich) α-HA (clone 12CA5), α-myc (clone 9E10), α-Pk (clone SV5-Pk1, 
AbD Serotec). Membranes were washed for 3 x 10 minutes with PBST before being 
incubated with α-mouse, α-rabbit or α-rat horseradish peroxidase (HRP) coupled 
secondary antibodies in PBST containing 4% milk for 30 minutes – 2 hours at room 
temperature. Membranes were washed a further three times before adding ECL 
(Amersham) according to the manufacturer’s instructions, and then were either 
developed using a developer or photographed using an ImageQuant las 4000 (GE 
Healthcare).  
2.2.3 Immunoprecipitation 
For immunoprecipitation, cell extracts were prepared in EBXG buffer (50 mM HEPES 
pH 8.0, 100 mM KCl, 2.5 mM MgCl2, 10% glycerol, 0.25% Triton X-100, 1 mM DTT, 
cOmplete protease inhibitor tablets - Roche) using glass bead breakage in a Multi Bead 
Shocker (Yasui Kikai) at 2°C. Extracts were cleared by centrifugation at 14800 rpm for 
30 minutes at 4°C, pre-cleared using Protein A Dynabeads for 2 hours, incubated with 
antibody for 1 hour, and finally adsorbed to Protein A Dynabeads for 2 hours. Beads 
were washed in EBXG and elution was carried out in SDS-PAGE loading buffer at 65°C 
for 20 minutes.  
2.2.4 Phosphatase assay 
For the in vitro Nur1 dephosphorylation assay, immunoprecipitation was performed as 
above, then beads were resuspended in phosphatase buffer (New England Biolabs) and 
1 µg λ phosphatase (New England Biolabs), or 8 µg purified recombinant Cdc14, kindly 
provided by C. Bouchoux (Bouchoux and Uhlmann, 2011), were added, followed by 
incubation at 30°C for 30 minutes before the reaction was stopped and proteins eluted 
by addition of SDS-PAGE loading buffer.  
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2.3 Molecular Biology and DNA manipulation 
2.3.1 Genomic DNA preparation 
Yeast genomic DNA for PCR genotyping was prepared from fresh patches of the strain 
of interest. Cells was resuspended in 100 µl 200 mM LiOAc 1% SDS solution, and 
incubated at 70°C for 15 min. After incubation, 300 µL 100% ethanol was added, and 
DNA was collected by centrifugation at 13000 rpm for 3 min. DNA Pellets were dried 
for 15 minutes at 30°C and dissolved in 50-100 µL TE. Cell debris was spun down by 
brief centrifugation (13000 rpm for 1 min), and 1 µL supernatant was used for PCR.  
2.3.2 Polymerase Chain Reaction (PCR) 
PCR reactions were carried out in 25 or 50 μl reactions containing Taq (Qiagen), 
Expand High Fidelity (Roche), or ClonAmp (ClonTech) polymerases with buffers 
supplied by the manufacturers, and if necessary 0.2 mM dNTPs as well as 0.5 μM of 
each primer. All PCRs were performed on a Peltier Thermal Cycler (MJ Research). PCR 
products were resolved by agarose gel electrophoresis to confirm the size of the 
fragments.  
2.3.3 Strain design 
2.3.3.1 Epitope tagging 
Epitope tagging of endogenous genes was performed by gene targeting using 
polymerase chain reaction (PCR) products (Bähler et al., 1998; Knop et al., 1999).  
Forward and reverse primers with homology to respectively the 3’ end of the gene of 
interest and the 3’UTR were used, also containing an 18-mer sequence homologous to 
the vector used for tagging. These were used to amplify the vector by PCR, with the 
subsequent product containing the epitope tag, a marker, and  a 50-mer sequence at 
each end homologous to the region of marker insertion.  
Chapter 2 Materials and Methods 
 
 61 
Transformants were subsequently selected on plates by using auxotrophic markers 
(derived from either Kluyveromyces lactis or S. pombe) to minimize the chance of 
integration at the marker locus, or G418 resistance.  
To generate the conditional Nur1-Clb2 and Nur1-Clb2ΔCdk fusions, as described in 
(Kuilman et al., 2015), Clb2 lacking its destruction and KEN-boxes (Wäsch and Cross, 
2002), as well as its nuclear localization sequence (Eluère et al., 2007), was fused to 
Nur1, separated by an unstructured 10-mer GGSGTGGSGT linker. In addition, the 
Clb2 fusion cassette contained an HA-epitope tag before Clb2, flanked by two LoxP 
sites, and an HA-epitope tag after Clb2. The Clb2ΔCdk mutant further contained 3 
point mutations (K316A, E345, F354A) that prevent it from interacting with the Cdc28 
kinase subunit (Bailly et al., 2003). The Clb2 fusion cassette, constructed on a plasmid, 
was amplified by PCR and targeted to Nur1 using homologous primers.  
2.3.3.2 Gene replacement and deletion 
Genes were deleted using PCR generated products (Bähler et al., 1998). A marker gene 
(LEU2, URA3, HIS3, TRP1) or KanMX6 was amplified with flanking sequences 
corresponding to the 5’ and 3’ ends of the relevant genes. Fragments were transformed 
into a strain lacking the selective marker. Colonies were selected on plates lacking the 
selective marker.  
The nur1(9A) mutant was engineered by endogenous gene replacement using an 
integrative plasmid, based on a synthetic DNA construct (GeneArt, Life Technologies).  
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2.3.3.3 PCR programme for C-terminal tagging and deletion of yeast 
proteins 
Step Time 
 
Temperature (°C)  
 
1 2 minutes 94 
2 15 seconds 94 
3 45 seconds 
50-60 depending on 
primer tm 
4 1 minute 30 seconds 72 
5  Go to step 2 and repeat 5X - 
6 15 seconds 94 
7 45 seconds 
55-65 depending on 
primer tm 
8 
1 minute 30 seconds + 5 
seconds/cycle 
72 
9 Go to step 6 and repeat 25X - 
10 7 minutes 72 
11 - 4 
 
Table 2.3 – PCR programme used for gene deletion and epitope tagging 
2.3.4 Vector List 
Number Description 
35 One-step C terminal tagging vector – HA3::K.l TRP 
554 One-step C terminal tagging vector – PK3::K.l TRP 
39 One-step C terminal tagging vector – myc18::K.l URA 
32 Gene deletion vector (pBlueScript Backbone) – K.l TRP 
210 Gene deletion vector (pBlueScript Backbone) – K.l URA 
211 Gene deletion vector (pBlueScript Backbone) – K.l LEU 
212 Gene deletion vector (pBlueScript Backbone) – K.l HIS 
1109 YIplac128-URA3-l30-Clb2 (conditional fusion construct) 
1110 
YIplac128-URA3-l30-Clb2ΔCdk (conditional fusion 
construct) 
518 YIplac211-GAL-Cdc14-Pk3::URA3 
MG1 prS305-Nur1(9A)- LEU2 
 
Table 2.4 – Vector List 
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2.3.5 Agarose gel electrophoresis 
DNA samples were loaded on a 0.8-2% agarose gel (depending on the size of the DNA 
fragment) in 6x loading buffer (0.25% w/v bromophenol blue, 0.25% w/v xylene cyanol, 
30% (v/v) glycerol). Agarose gels were prepared in 1x Tris-acetate EDTA buffer (TAE) 
(40 mM Tris base pH 7.5, 1 mM EDTA pH 8.0, 0.115% v/v acetic acid), to which 
GelRed (Biotium, Inc.) was added to a final concentration of 0.5 μg/ml. Electrophoresis 
was carried out in TAE at 80- 120 V in electrophoresis tanks from Anachem.  
2.4 Microscopy and Cell Biology 
2.4.1 Spheroblastation 
Cells were fixed in buffer IF1 (100 mM potassium phosphatase pH 6.8, 0.5 mM MgCl2) 
with 3.7% formaldehyde, washed in buffer IF1 without formaldehyde, then washed 
again in buffer IF2 (100 mM potassium phosphatase pH 7.4, 0.5 mM MgCl2, 1.2 M 
Sorbitol). Cells were incubated at 37°C for 30 minutes in spheroblasting buffer (IF2 
with 2% lyticase and 2% β-mercaptoethanol), washed once in IF2, and resuspended in 
IF2 before stored at – 20°C.  
2.4.2 Immunofluorescence 
Indirect immunofluorescence was performed on formaldehyde-fixed, spheroblasted  
cells, using 15-well slides (MP Biomedicals). Cells were fixed on the slides using Poly-l-
lysine, and mounted using ProLong Gold. The antibodies used for 
immunofluorescence are described in table 2.3The following antibodies were used: α-
GFP, (clone TP401, Torrey Pines Biolabs or ab6556, Abcam), α-Tub1 (clone YOL1/ 34, 
AbD Serotec) and FITC and Cy3-dye labeled secondary antibodies (Sigma and 
Chemicon, respectively). Cells were counterstained with the DNA binding dyes 4’,6-
diamidino-2- phenylindole (DAPI), or Hoescht, present in the mounting media 
ProLong Gold at a concentration of 100 ng/ml. Fluorescent images were acquired using 
an Axioplan 2 imaging microscope (Zeiss) equipped with a 100x (NA = 1.45) Plan-
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Neofluar objective and an ORCA-ER camera (Hamamatsu). Spindle length 
measurements were carried out in ImageJ. 
2.4.3 Cell cycle analysis by Flow Cytometry (FACS) 
Cells were fixed in ethanol for 2-24 hours at 4°C, RNase treated in 50 mM Tris-HCl pH 
7.5 with 0.1 mg/ml RNase A for 2-24 hours at 37°C, and resuspended in propidium-
iodide containing buffer (200 mM Tris-HCl pH 7.5, 211 mM NaCl, 78 mM MgCl2, 
50μg/ml propidium iodide). Cells were sonicated (Sanyo, Soniprep 150) before being 
analysed on a FACScan, or a FACSCalibur (Becton Dickinson). DNA content profiles 
were prepared using FlowJo.  
2.5 Stable Isotope Labelling In Culture 
2.5.1 Sample preparation 
Cell cultures were grown for > 8 generations in heavy or light media, arrested and 
released then mixed and collected. 45 ml of cells was added to 5 ml 100 % TCA, and the 
samples left to precipitate on ice for >30 min. Cells were spun down and the pellets 
washed with acetone. Pellets were resuspended in beating buffer (8 M urea, 5 mM 
EDTA, 50 mM ammonium bicarbonate). 0.5 mm glass beads (Biospec Products, Inc)  
were added and the cells were lysed using glass bead breakage in a Multi Bead Shocker 
(Yasui Kikai) at 2°C. The supernatant was separated from the beads and spun down at 
14800 rpm for 10 min, to remove cell debris. Supernatant was collected and frozen at -
80°C.  
2.5.2 Sample processing for mass spectrometry 
From this point onwards, all procedures were carried out by members of the Crick 
Protein Analysis and Proteomics facility.  
Samples were reduced with 1 M dithiothreitol  (DTT) for 25 min at 56°C, alkylated with 
500 mM iodoacetamide for 30 min at room temperature protected from light and 
quenched with 1 M dithiothreitol. Samples were then diluted with 50 mM ammonium 
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bicarbonate to reduce the urea concentration to <2 M prior to an overnight trypsin 
digestion at 37°C. The peptides were acidified to 0.4 % with trifluoroacetic acid (TFA) 
and centrifuged at 14000 rpm at 4°C for 30 min. Peptides were then desalted using a C18 
SepPak Lite, 130 mg bed volume, under vacuum and dried. They were then digested 
using Lys-C in 10 % acetonitrile, 50 mM ammonium bicarbonate at 37°C for 2 h, 
followed by trypsin digestion at 37°C overnight. Digested peptides were then again 
desalted and dried.  
Titanium dioxide enrichment was then carried out: dried fractions were re-suspended 
in 80% acetonitrile, 5% trifluoroacetic acid, 1 M glycolic acid, sonicated for 10 min and 
added to 5 mg of titanium dioxide beads. The beads were washed using 80% acetonitrile 
and 1% trifluoroacetic acid followed by 10% acetonitrile and 0.2% trifluoroacetic acid, 
and dried under centrifugation. Phosphopeptides were then eluted from the beads by 
adding 1% ammonium hydroxide followed by 5% ammonium hydroxide, and dried by 
vacuum centrifugation. 
Dried phosphopeptides were then re-suspended in 100 µl of 1% trifluoroacetic acid and 
sonicated for 15 min. A C18 membrane was packed into a 200 µl pipette tip and washed 
using methanol and equilibrated with 1% trifluoroacetic acid. The peptides were then 
loaded onto the Stage Tip and washed with 1% trifluoroacetic acid followed by elution 
with 80% acetonitrile, 5% trifluoroacetic acid. The eluted peptides were again dried 
under vacuum centrifugation. 
2.5.3 Data acquisition by mass spectrometry 
For LC-MS/MS data acquisition analysis, the following was performed: Peptide 
mixtures were re-suspended in 35 µl 0.1% trifluoroacetic acid, and injected three times 
(10 µl per injection). Each run consisted of a 3 h gradient elution with one activation 
method per run: CID, MSA and HCD. An LTQ-Orbitrap Velos was used for data 
acquisition. 
Data processing was performed using the MaxQuant bioinformatics suite as adopted by 
the Crick Protein Analysis and Proteomics facility, and protein database searching was 
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performed by the Andromeda search engine using a UniProt database of S. cerevisiae 
proteins amended with common contaminants. Data was analysed using the Perseus 
software package. 
2.6 Summary of antibodies used 
Antibodies used for western blot (WB), immunoprecipitation (IP) and 
immunofluorescence (IF), and the concentrations used are detailed in table 2.5. 
Antigen Provenance and description 
Dilution/Amount 
WB IP IF 
Clb2 Santa Cruz, sc9071 (0.2 mg/ml) - Rabbit 
1/500-
1/1000   
Orc6 
In house, clone SB49 (1.1 mg/ml) - 
Mouse 1/1000   
Sic1 Santa Cruz, sc50441 (0.2 mg/ml) - Rabbit 1/500   
Tub1 
Clone YOL1/34, AbD Serotec (1 mg/ml) 
- Rat 1/1000  1/200 
Tat1 Sigma-Aldrich (1.5 mg/ml) - Mouse 1/10000   
HA Clone 12CA5, Abcam (1 mg/ml) - Mouse 1/5000   
myc 
In house, clone 9E10 (1.2 mg/ml) - 
Mouse 1/5000 5 µg  
Pk Clone SV5-Pk1 AbD Serotec - Mouse 1/5000   
GFP 
clone TP401, Torrey Pines Biolabs (1 
mg/ml) – rabbit    1/100 
GFP Ab6556, abcam - Rabbit   1/100 
Mouse IgG GE Healthcare – HRP-coupled secondary 1/5000   
Rabbit IgG GE Healthcare – HRP-coupled secondary 1/5000   
Rat IgG GE Healthcare – HRP-coupled secondary 1/5000   
Rat IgG Sigma – Cy3-Coupled secondary   1/500 
Rabbit IgG Chemicon – FITC-coupled secondary   1/200 
 
Table 2.5 – Antibody list 
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2.7 Summary of buffers and solutions used and their 
compositions 
Buffer name/ 
Abbreviation Composition 
 
Section Ref. 
 
TL 
10 mM Tris/HCl pH 7.5, 100 mM EDTA, 100 mM 
Lithium acetate 
2.1.3 
TELP TEL plus 40% Poly-ethylene-glycol 3350 or 4000 2.1.3 
Tris-Base 1 M Tris-Base (no pH) 2.2.1 
2X SDS  
100 mM Tris-HCl pH 6.8, 200 mM DTT, 4% SDS, 
0.1% Bromophenol Blue, 20% Glycerol 
2.2.1 
SDS-Page 
running buffer 25 mM Tris, 250 mM Glycine, 0.1% Sds 
2.2.2 
Transfer Buffer 
3.03g/l Tris base 14.1 g/l glycine, 0.05%SDS 20% 
w/v methanol 
2.2.2 
PBST 
Phosphatase Buffered Saline Tween – 170 mM 
NaCl, 3 mM KCl, 10 mM Na2HPO4, 2 mM 
KH2PO4, 0.01% Tween20 
2.2.2 
EBXG 
50 mM HEPES pH 8.0, 100 mM KCl, 2.5 mM 
MgCl2, 10% glycerol, 0.25% Triton X-100, 1 mM 
DTT, cOmplete protease inhibitor tablets - Roche 
2.2.3 
DNA extraction  200 mM LiOAc, 1% SDS 2.3.1 
TE 10 mM Tris-HCl pH 8, 1 mM EDTA 2.3.1 
6X DNA loading 
buffer 
0.25% w/v bromophenol blue, 0.25% w/v xylene 
cyanol, 30% (v/v) glycerol 
2.3.4 
TAE 
40 mM Tris base pH 7.5, 1 mM EDTA pH 8.0, 
0.115% v/v acetic acid 
2.3.4 
IF1 
100 mM potassium phosphatase pH 6.8, 0.5 mM 
MgCl2 
2.4.1 
IF2 
100 mM potassium phosphatase pH 7.4, 0.5 mM 
MgCl2, 1.2 M Sorbitol 
2.4.1 
Spheroblasting 
buffer IF2 + 0.2% lyticase and 0.2% β-mercaptoethanol 
2.4.1 
70% EtOH 70% ethanol in H2O 2.4.2 
RNase buffer  50 mM Tris-HCl pH 7.5 2.4.2 
FACS buffer 
200 mM Tris-HCl pH 7.5, 211 mM NaCl, 78 mM 
MgCl2, 50μg/ml propidium iodide 
2.4.2 
 
Table 2.6 – Summary of buffers and solutions 
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Chapter 3. Results: Nur1 dephosphorylation 
confers positive feedback to Cdc14 activation 
As discussed in Chapter 1, a role for the Cdk-opposing phosphatase Cdc14 in 
controlling rDNA condensation and segregation is established, however which proteins 
Cdc14 is targeting to control this process remains unclear. Therefore, my initial 
approach was to try and identify Cdc14 targets that could be important for the accurate 
completion of rDNA condensation and/or segregation.  
These targets will likely be dephosphorylated in anaphase, when these processes occur. 
With this in mind, I reviewed the results of a phosphoproteomics-based screen for 
novel Cdc14 targets in budding yeast mitotic exit (carried out by Thomas Kuilman) for 
targets which met our criteria (Kuilman et al., 2015). This screen exploited the fact that 
Cdc14 targets are dephosphorylated in an ordered manner, relative to the ratio of 
kinase/phosphatase activity in the cell.  Briefly, cells were arrested in metaphase using 
an S. cerevisiae strain in which Cdc20, a subunit of the APC/C complex necessary for 
the progression from metaphase to anaphase, is not expressed. In these conditions Cdk 
activity is maintained at a constant level and endogenous Cdc14 is sequestered in the 
nucleolus. In this metaphase arrest Cdc14, itself under control of a GAL-inducible 
promoter, was expressed. This forced cells to undergo some aspects of mitosis, targets 
being dephosphorylated depending on the increasing activity of the phosphatase. For 
several examples, the order of dephosphorylation of Cdc14 targets mirrored that in a 
normal cell cycle. By using mass spectrometry to measure the disappearance of Cdk-
phosphorylated phosphopeptides, this approach led to the identification of various 
novel Cdc14 targets (Kuilman et al., 2015). 
As a candidate protein that could be involved in the regulation of rDNA, we selected 
the nuclear envelope protein Nur1 for further study. Along with its main binding 
partner Src1/Heh1, this protein has been designated a “Chromosome Linkage INM 
Protein”. It has been demonstrated to be important for the tethering of the rDNA and 
telomeres to the nuclear envelope, its absence leading to a decrease in rDNA repeat 
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stability and unequal rDNA segregation as well as loss of telomeric stability and 
telomere silencing (Mekhail, Seebacher, Gygi and Moazed, 2008; Chan et al., 2011; 
Poon and Mekhail, 2011). Further, this protein was previously identified as a Cdk target 
in a proteome wide study (Ubersax et al., 2003). Nur1 is predicted to have nine Cdk 
sites (two full and seven minimal sites), four of which have also been identified in mass 
spectrometry studies (Holt et al., 2009; Kuilman et al., 2015). It has two predicted 
helical trans-membrane domains, as well as a putative C-terminal nuclear localisation 
signal (Fig. 1A). 
3.1 Nur1 is a Cdc14 target in anaphase 
Of the four Nur1 Cdk sites confirmed by mass spectrometry, T. Kuilman’s  
phosphoproteome analysis covered three phosphorylation sites on two 
phosphopeptides. These disappeared with early to intermediate timing, relative to the 
phosphopeptides of all detected proteins, during Cdc14 induced mitotic exit (Fig. 3.1B). 
This is compatible with the protein being dephosphorylated in anaphase.  
In order to confirm that the protein was indeed dephosphorylated at this cell cycle stage 
in vivo, in a Cdc14-dependent manner, I carried out cell cycle analysis of the 
phosphorylation of the protein by looking for mobility shifts on a Phos-tag acrylamide 
gel. Cells were arrested in G1 by pheromone α-factor treatment, released at 35.5°C to 
progress through the cell cycle, and either rearrested in the following G1 in a wild type 
situation, or arrested at mitotic exit in a cdc14-1 strain lacking Cdc14 activity at the 
restrictive temperature. Progression through the cell cycle was monitored by FACS 
analysis of DNA content.  
In the wild type, Nur1 became phosphorylated by S phase, as evidenced by the 
appearance of slower migrating isoforms of the protein (Fig. 3.1C), Faster migrating 
isoforms of the protein reappeared 60-75 minutes after release from G1, consistent with 
the protein being dephosphorylated during anaphase, before cells completed 
cytokinesis at around 90 minutes (Fig. 3.1C).   
Chapter 3 Results 
 
 70 
In the cdc14-1 background, after Cdc14 inactivation, the faster migrating forms of Nur1 
never reappeared, indicating that Nur1 is not dephosphorylated in this case (Fig. 3.1C). 
To confirm that Cdc14 is directly responsible for dephosphorylating Nur1, and that the 
mobility shift observed on the gel is indeed due to phosphorylation, Nur1 was 
immunoprecipitated from mitotic cells arrested by treatment with nocodazole. The 
immunoprecipitated protein was then incubated either in a control buffer, or in the 
presence of commercially available λ phosphatase, or purified recombinant Cdc14 (a 
gift from C. Bouchoux)(Bouchoux and Uhlmann, 2011). Incubation with either 
phosphatase, but not the control buffer, led to the conversion of Nur1 from the slower 
migrating to the faster migrating species, confirming that the slower migrating forms 
are the consequence of phosphorylation (Fig. 3.1D).  
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Figure 3.1 – Nur1 dephosphorylation by Cdc14 in anaphase.  
A. Schematic representation of Nur1. Putative (black) and confirmed (red) Cdk 
phosphorylation sites, as well as other predicted landmarks, are indicated. P1, 
SLpSPLRKpTPLSAR; P2, NDINSILRpSPK. B. Nur1 phosphopeptide abundance over 
the course of Cdc14-induced mitotic exit. C. Nur1 phosphorylation-dependent 
mobility shifts during synchronous cell cycle progression at 35.5°C, in wild-type and 
cdc14-1 cells, were analyzed using Phos-tag gels and Western blotting. Cell cycle 
progression was monitored by FACS analysis of DNA content. D. In vitro 
dephosphorylation of Nur1 by Cdc14. Immunopurified Nur1 was subjected to the 
indicated phosphatase or control treatments and analyzed by Phos-tag gel 
electrophoresis. 
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3.2 Nur1 dephosphorylation by Cdc14 is required for cell 
survival at high temperatures 
In order to examine the importance of Nur1 dephosphorylation, we created a strain in 
which Nur1 is fused to Clb2 in an inducible fashion (technique adapted from (Lyons 
and Morgan, 2011)). This strategy relies on the integration of Clb2 after the gene of 
interest, between which a marker is situated. The marker is flanked by LoxP sites and 
can be removed through the action of CRE-ER, itself activated upon the addition of β-
estradiol, leading to the transcription of the fusion protein (Fig. 3.2A). Due to the 
presence of Clb2, Cdc28 will be permanently recruited to Nur1 and lead to 
hyperphosphorylation of the protein.  As a control, a version of Clb2 harbouring three 
point mutations that prevent it from binding to and recruiting Cdc28 was also fused to 
Nur1 (Nur1-Clb2ΔCdk fusion). The replacement of the endogenous protein with the 
larger fusion protein is an efficient process and complete within 4 hours of induction. 
The Nur1-Clb2 fusion protein has a smeary aspect on a western, indicative of the 
presence of slower migrating forms characteristic of protein phosphorylation. This 
smear or haze was not present in the Nur1-Clb2ΔCdk fusion (Fig. 3.2C). 
It was next examined what effect the fusions would have on cell survival. Strikingly, the 
Nur1-Clb2 fusion was viable at 25°C but unable to grow at the higher temperature of 
36°C, whereas the Nur1-Clb2ΔCdk fusion was viable at both temperatures. This 
approach, however, does not take into account the possibility that the phenotype could 
be caused by Cdc28 phosphorylating other proteins in the vicinity of Nur1, having been 
attracted to the nucleolus in higher than usual levels, or phosphorylating non-
consensus sites within the protein.  In order to control for these scenarios, we created a 
version of Nur1 in which the 9 putative Cdk sites were replaced by alanines (Nur1(9A)). 
The process of generating Nur1(9A)-Clb2 and Nur1(9A)-Clb2ΔCdk fusions was then 
repeated. 
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This mutation of the 9 Cdk sites completely rescued the lethality of the Nur1-Clb2 
fusion (Fig. 3.2B). It also prevented the mobility shift following Nur1-Clb2 fusion (Fig. 
3.2D). This suggests that indeed persistent Nur1 phosphorylation on its Cdk 
phosphorylation sites is the cause for a temperature sensitive growth defect. 
 
Figure 3.2 – Creation of an inducible Nur1-Clb2 fusion causes cell death at high 
temperatures 
A. Design scheme of the Nur1-Clb2 fusion strains. B. Western blot demonstrating 
replacement of endogenous Nur1 with Nur1-Clb2, or Nur1-Clb2ΔCdk, 4 hours after β-
estradiol addition. C. Serial dilution assay to compare survival of Nur1-Clb2, Nur1-
Clb2ΔCdk, Nur1(9A)-Clb2 and Nur1(9A)-Clb2ΔCdk-expressing cells, at 25°C and 
36°C. D. Western blot demonstrating replacement of Nur1 or Nur1(9A) with Nur1-
Clb2 and Nur1(9A)-Clb2, respectively, 4 hours after β-estradiol addition.  
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3.3 Nur1 dephosphorylation promotes timely rDNA 
segregation 
3.3.1 Phosphorylated Nur1 delays rDNA segregation 
To study the effect of permanent phosphorylation of Nur1 on rDNA segregation, Net1, 
an abundant rDNA binding protein, was visualised by tagging with YFP and 
performing indirect immunofluorescence, in order to monitor the behaviour of the 
rDNA. Cells were synchronised in G1 by pheromone α-factor treatment, released to go 
through the cell cycle at 36°C, and the timing of rDNA segregation was monitored as 
the cells progressed through mitosis. The segregation of the rDNA – whether or not the 
rDNA had separated into two halves at opposite poles of the cell – was quantified 
relative to the length of the anaphase spindle, as an internal control for progression 
through anaphase. 
Both in a wild type strain and in the Nur1-Clb2ΔCdk control strain, complete rDNA 
segregation was initially recorded at a spindle length of 5-6 μm and was observed in 
100% of cells by the time spindles reached 8-9 μm. Conversely, in the Nur1-Clb2 strains, 
complete rDNA segregation was only observed from spindle lengths of 7-8 μm, and 
even when the spindle was fully elongated, at a length of 9-10 μm or more, rDNA 
segregation was still not complete in all cells at 36°C (Fig. 3.3A). A defect in rDNA 
segregation was also observed, although less pronounced, at 25°C (Fig. 3.4). 
Observations of the condensation state of the rDNA by immunofluorescence revealed 
that the wild-type or Nur1-Clb2ΔCdk control showed the appropriate highly 
condensed form for this locus in anaphase, neatly segregated to two the poles of the 
dividing cell. In contrast, in the Nur1-Clb2 strain the rDNA appeared more 
uncondensed, and often stretched out between the two cells across the bud neck (Fig. 
3.3B). From these observations it can be concluded that constitutive phosphorylation of 
Nur1 leads to defective rDNA segregation.  
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Figure 3.3 – Nur1-Clb2 delays rDNA segregation 
A. rDNA segregation as a function of spindle length, compared between Nur1-Clb2 
and Nur1-Clb2ΔCdk-expressing strains. At least 15, but typically more, cells were 
scored for each spindle length category. The mean and standard deviation from three 
independent experiments is shown. Wild type and Nur1(9A)-Cdk strains were also 
included in one repeat of the experiment. B. Representative images of rDNA 
segregation in a Nur1-Clb2ΔCdk cell, and of an anaphase bridge formed of rDNA in a 
Nur1-Clb2 cell. The rDNA was visualized by the rDNA binding protein Net1, fused to 
YFP, the spindle was detected with an antibody against α-tubulin, DNA was stained 
with 4’,6-diamidino-2-phenylindole (DAPI). C. ADE2 marker loss from the rDNA 
repeats is shown as a percentage of half red-sectored colonies after plating the indicated 
strains, with D. A representative field of colonies shown for each genotype. Around 500 
colonies were scored for each strain. The mean and standard deviation from four 
independent experiments is shown. 
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A possible consequence of defective rDNA segregation is unequal segregation of this 
locus between the mother and daughter cells. To measure rDNA stability, we quantified 
the rate of loss of an ADE2 marker integrated within the rDNA repeats. Loss of ADE2 
causes accumulation of a red intermediate metabolite in the adenine synthesis pathway, 
leading to the growth of red colonies when cells are plated on low adenine media. ADE2 
loss during the first cell division after plating will generate half red-sectored colonies. 
The Nur1-Clb2 fusion strains have a significant increase in the fraction of half-sectored 
colonies, compared to the Nur1-Clb2ΔCdk or wild-type strains. This indicates that 
there is not only a delay in rDNA segregation, but also mis-segregation of the repeats in 
a certain fraction of the affected cells (Fig. 3.3C-D).  
3.3.2 Cdc14 overexpression rescues the rDNA segregation delay 
To confirm that it is indeed lack of dephosphorylation by Cdc14 that is responsible for 
the delay in rDNA segregation, an extra copy of Cdc14 was integrated in the Nur1-Clb2 
strain and the Nur1-Clb2ΔCdk control strain, under the control of a galactose-
inducible promoter (GAL-CDC14). In an experiment in which cells were arrested in G1 
by α-factor pheromone treatment and released to progress through the cell cycle, 
overexpression of Cdc14 from metaphase onwards led to disappearance of the slower 
migrating forms of Nur1-Clb2, indicating that the protein may be dephosphorylated 
(Fig. 3.5A). Monitoring the segregation of the rDNA relative to the length of the 
anaphase spindle, as previously, it was found that Cdc14 overexpression rescued the 
rDNA segregation delay observed in the Nur1-Clb2 fusion.  
Figure 3.4 – rDNA segregation is 
delayed in Nur1-Clb2 at 25°C   
rDNA segregation as a function of 
spindle length, compared between Nur1-
Clb2 and Nur1-Clb2ΔCdk-expressing 
strains. At least 15, but typically more, 
cells were scored for each spindle length 
category. 
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Figure 3.5 – Cdc14 overexpression rescues rDNA segregation defect in the Nur1-
Clb2 fusion strain.  
A. Overexpression of Cdc14 from a Galactose inducible promoter from metaphase 
onwards leads to dephosphorylation of Nur1-Clb2. Cells were grown in YP+raffinose 
and galactose was added 60 minutes after release from G1. The arrow in the right 
indicates Cdc14-PK expression. B. rDNA segregation in the Nur1-Clb2 strain was 
rescued by overexpression of Cdc14, in the same experiment.  
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3.4 Persistent Nur1 phosphorylation delays mitotic 
progression 
Given Nur1's role as a nuclear rim protein and its direct contacts with rDNA-binding 
proteins, one possibility is that Nur1 plays a direct role in regulating the condensation 
status of the rDNA, influencing its ability to segregate correctly. On the other hand, 
delayed rDNA segregation is a hallmark of defects in mitotic exit, for instance being a 
characteristic phenotype of FEAR pathway mutants, so a second possibility is that the 
phenotype observed is a consequence of a higher level defect in the process of mitotic 
exit itself.  
In order to test this hypothesis, cells were arrested in G1 by α-factor treatment, released 
to progress through the cell cycle in a synchronous manner at 36°C, and rearrested in 
the following G1, during which experiment the timing of progression through mitosis 
was monitored. FACS analysis showed that Nur1-Clb2 cells spent at least 20 minutes 
longer with a 2C DNA content than a Nur1-Clb2ΔCdk control, indicative of a delay 
somewhere in mitosis (Fig. 3.6A). To investigate in more detail at which stage the delay 
was occurring, several cell cycle markers were examined by Western blot at frequent 
intervals throughout the cell cycle. The timing of appearance of Clb2 and Securin  (S 
phase) was identical between Nur1-Clb2 and the Nur1-Clb2ΔCdk control, as was the 
similarly timed phosphorylation of Orc6. However, the disappearance of both Clb2 and 
Securin were markedly delayed, as were the dephosphorylation of Orc6 during mitotic 
exit and re-accumulation of the Cdk inhibitor and G1 marker, Sic1 (Fig. 3.6B). To 
distinguish whether the delay took place before or after the metaphase-anaphase 
transition, the proportion of metaphase spindles (1-3 μm) versus anaphase spindles (>3 
μm) was quantified at 10-minute intervals as cells progressed synchronously through 
mitosis.  There was a slight delay in progression through metaphase, but more 
strikingly a long prolongation of the time that Nur1-Clb2 cells spent with anaphase 
spindles (Fig. 3.6C). These observations are consistent with a delay of Nur1-Clb2 cells 
both at the metaphase to anaphase transition as well as during mitotic exit. A similar 
delay in mitotic progression, although less pronounced, was observed in the same 
experiment done at 25°C (Fig. 3.7). 
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Figure 3.6 – Nur1-Clb2 causes a mitotic exit defect at 36°C 
Nur1-Clb2 and Nur1-Clb2ΔCdk cells were synchronized in G1 by a-factor treatment 
and released to progress through the cell cycle at 36°C, before being rearrested in the 
following G1. At time points throughout the cell cycle we monitored, A. Cell cycle 
progression by FACS analysis of DNA content. B. Western blot analysis of the cell cycle 
markers securin, Clb2, Sic1 and Orc6, and C. The percentages of cells displaying 
metaphase (1–3 mm) or anaphase (≧3 mm) spindles were scored. 100 cells were 
counted at each time point.  
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Figure 3.7 – Nur1-Clb2 causes a mitotic exit defect at 25°C 
Nur1-Clb2 and Nur1-Clb2ΔCdk cells were synchronized in G1 by a-factor treatment 
and released to progress through the cell cycle at 25°C, before being rearrested in the 
following G1. At time points throughout the cell cycle we monitored, A. Cell cycle 
progression by FACS analysis of DNA content and B. The percentages of cells 
displaying metaphase (1–3 mm) or anaphase (≧3 mm) spindles were scored. 100 cells 
were counted at each time point.  
 
Chapter 3 Results 
 
 81 
 
Figure 3.8 – Nur1 phosphorylation is responsible for the mitotic exit delay seen in 
Nur1-Clb2 cells 
Nur1-Clb2 and Nur1-(9A)Clb2 cells were synchronized in G1 by a-factor treatment 
and released to progress through the cell cycle at 36°C, before being rearrested in the 
following G1. At time points throughout the cell cycle we monitored, A. Cell cycle 
progression by FACS analysis of DNA content. B. Western blot analysis of the cell cycle 
markers Clb2, Sic1 and Orc6, and C. The percentages of cells displaying metaphase (1–
3 mm) or anaphase (≧3 mm) spindles were scored. 100 cells were counted at each time 
point.  
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To confirm that the delay was due to constitutive phosphorylation of Nur1, we repeated 
the same experiment using the Nur1(9A)-Clb2 fusion as a control instead of Nur1-
Clb2ΔCdk. We found that the Nur1(9A)-Clb2 completely rescued all aspects of mitotic 
progression – according to FACS analysis, western blot of cell cycle markers, and 
monitoring of spindle morphology (Fig. 3.8). 
This leads us to conclude that the delay in rDNA segregation is likely due to a higher-
level delay in mitotic exit itself, for which constitutive Nur1 phosphorylation is 
responsible.  
3.5 Phospho-Nur1 plays a role in sequestering Cdc14 
3.5.1 Nur1-Clb2 delays Cdc14 release 
The mitotic exit delay in Nur1-Clb2 fusion cells is reminiscent of that seen in FEAR 
pathway mutants, in which a delay in activation of the Cdc14 phosphatase leads to 
delayed mitotic exit and rDNA segregation. Given the similarities in phenotype 
between mutants with delayed Cdc14 release and our Nur1-Clb2 fusion mutant strain, I 
decided to investigate the timing of Cdc14 release in the latter. Again, cells were 
synchronized in G1 and the timing of Cdc14 release was measured as cells passed 
through mitosis. As with the investigation of rDNA segregation, release of Cdc14 was 
quantified relative to the length of the mitotic spindle, as an internal control for the 
timing of progression through mitosis.  
I found over several experimental repeats that there was a small but statistically 
significant delay (p<0.005) in the timing of Cdc14 release from the nucleolus in the 
Nur1-Clb2 fusions as compared to the Nur1-Clb2ΔCdk control (Fig. 3.9).  This 
indicates that phosphorylated Nur1 is impeding Cdc14 release, which in turn would be 
responsible for the delay in mitotic exit and rDNA segregation.  
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Figure 3.9 – Nur1-Clb2 delays Cdc14 release 
Quantification of Cdc14 release, in experiments performed as in Figure 3.6, relative to 
spindle length. At least 15, but typically more, cells were counted for each spindle 
length category. The mean and standard deviation from 3 independent experiments is 
shown. A logistic regression analysis showed that Cdc14 release timing in the Nur1-
Clb2 strain was significantly delayed. 
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3.5.2 CDC14TAB6-1  rescues survival and mitotic progression of Nur1-Clb2 
 If phosphorylated Nur1 is preventing Cdc14 from being released, then inserting the 
dominant active CDC14TAB6-1 allele, which leads to Cdc14 being less tightly bound by 
Net1, should restore cell survival at high temperature. This allele was able to completely 
rescue growth of Nur1-Clb2 at 36°C (Fig. 3.10A). As a control, it was confirmed 
that CDC14TAB6-1 did not cause dephosphorylation of Nur1-Clb2, due to the presence of 
higher than normal levels of Cdc14 activity. Western blotting revealed that Nur1-Clb2 
mobility, in particular its slower migrating forms, is unaffected by the presence 
of CDC14TAB6-1 (Fig. 3.10B). Therefore the temperature sensitive growth due to 
persistent Cdk phosphorylation of Nur1 is caused by defective Cdc14 activation.  
Progression through the cell cycle was monitored in Nur1-Clb2 with and without 
CDC14TAB6-1. FACS analysis and Western blotting of the cell cycle markers Clb2 and 
Sic1 revealed that normal cell cycle progression was largely restored, with the delay at 
the metaphase to anaphase transition and during mitotic exit being rescued (Fig. 310C-
D). This was further confirmed by monitoring of spindle morphology, where it was 
noted that normal progression through mitosis was restored (Fig. 3.10E).  
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Figure 3.10 – Cdc14TAB6-1 rescues Nur1-Clb2 
A. Serial dilution assay demonstrating rescue of cell survival of Nur1-Clb2 cells by 
dominant active Cdc14TAB6-1. B. Western blot samples taken of the cells in B, before they 
were plated, shows that Cdc14TAB6-1 did not alter the Nur1-Clb2 phosphorylation status. 
C.-E. Active Cdc14 rescues mitotic progression of Nur1-Clb2 cells. As in Figure 3.6, 
but strains carried the CDC14TAB6-1 allele. 
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We can conclude from these experiments that Nur1, and more specifically 
phosphorylated Nur1, is preventing Cdc14 from being properly released in early 
anaphase, thus causing defective mitotic exit. If this is the case, it can be postulated that 
either eliminating Nur1 or removing its Cdk phosphorylation sites should therefore 
facilitate Cdc14 release.  
3.6 Phospho-Nur1 counteracts Cdc14 release in early 
anaphase 
3.6.1 nur1Δ or nur1(9A) cause premature Cdc14 release  
To test this hypothesis, a detailed study into the timing of Cdc14 release, looking both 
at partial (with Cdc14 still enriched in the nucleolus but also present in the nucleus 
and/or cytoplasm) and full release, was carried out. Again, G1-G1 experiments were 
performed in which wild-type, nur1Δ, and nur1(9A) strains were compared, with 
Cdc14 release state related to spindle length. 
Three independent experiments corroborated the fact that Cdc14 was indeed released 
both earlier and more abruptly in cells lacking Nur1. Strikingly, Cdc14 was detected, 
either partially or fully released, in more than half of Δnur1 or nur1(9A) cells at spindle 
lengths below 3 µm, when Cdc14 release is almost never seen in wild type cells. Even in 
metaphase cells with short (1-2 µm) spindles, when Cdc14 is usually kept tightly 
sequestered in the nucleolus, Cdc14 release was observed in a small proportion of 
Δnur1 or nur1(9A) cells (Fig. 3.11A). Representative images are shown of metaphase 
cells, in wild-type strains with Cdc14 sequestered in the nucleolus, and in nur1Δ with 
Cdc14 fully released (Fig. 3.11B).  
 
 
Chapter 3 Results 
 
 87 
 
Figure 3.11 – Absence of Nur1 or of its Cdk phospho-sites leads to early Cdc14 
release 
A. Quantification of Cdc14 release versus spindle length, as in Fig. 3.9, in wild type, 
nur1Δ and nur1(9A) cells. Cdc14 release was subdivided into ‘Partial release’, when 
Cdc14 was detectably released into the nucleus but some nucleolar enrichment 
persisted and ‘Full release’, when no nucleolar Cdc14 enrichment remained detectable. 
The mean and standard deviation from three independent experiments is shown. B. 
Images of Cdc14 in wild type and nur1Δ cells. The metaphase state is confirmed by the 
presence of a short spindle, stained with an a-tubulin antibody. Cdc14-GFP was 
detected with an a-GFP antibody, DNA was counterstained with DAPI. 
 
3.6.2 Premature Cdc14 release does nor affect the Spindle Assembly 
Checkpoint 
Early Cdc14 release could in theory lead to defective activation of the Spindle Assembly 
Checkpoint (SAC). Indeed, one of the early anaphase roles of Cdc14 is to inactivate the 
checkpoint by dephosphorylating Sli15 (forming part of the chromosome tension 
sensor) (Mirchenko and Uhlmann, 2010). If Cdc14 were released too early, Sli15 could 
already be dephosphorylated, leading to an inability of cells to respond to checkpoint 
defects. To test whether this was the case, we examined nur1Δ cells’ sensitivity to the 
microtubule depolymerising drug benomyl – if cells are unable to activate the SAC, 
they should die in the presence of this drug, as is the case in a mad2Δ background. 
Chapter 3 Results 
 
 88 
However, we found that nur1Δ cells behave as wild type when grown in the presence of 
benomyl (Fig. 3.12). We hypothesise that while Cdc14 is released early in nur1Δ and 
nur1(9A) cells, at times before anaphase onset this amounts to a small increase in 
Cdc14 concentration that is probably not enough to shift the kinase to phosphatase 
ratio far enough to have any significant effect on the phosphorylation state of mitotic 
exit proteins.  
 
Figure 3.12 – Early Cdc14 release does not cause SAC activation 
Serial dilution assay to compare survival of wild type, mad2Δ and nur1Δ cells in the 
presence of 10 µg/ml benomyl.  
3.6.3 nur1Δ or nur1(9A)  can rescue FEAR pathway mutants 
In wild type, Cdc14 activation is promoted by the FEAR network in early anaphase. To 
further understand the role of Nur1 in Cdc14 release at this time, we introduced nur1Δ 
and nur1(9A) alleles into a spo12Δ strain, lacking a key component of the FEAR 
network (see Section 1.4). As previously, Cdc14 release was related to spindle length in 
synchronous cell cycle experiments, and it was quantified whether Cdc14 was partially 
or fully released.  
In spo12Δ alone, Cdc14 release is severely delayed, with cells only showing released 
Cdc14 when spindles reached 6 µm. By introducing nur1Δ and nur1(9A) into this 
background, Cdc14 release was restored in early anaphase. The Cdc14 release profile in 
the nur1Δ spo12Δ and nur1(9A) spo12Δ double mutant strains was similar to that of 
wild type cells. However, at short spindle lengths, nur1Δ spo12Δ and nur1(9A) spo12Δ 
cells still displayed premature and more extensive Cdc14 release, as compared to wild 
type, while at longer spindle lengths the rescue did not fully reach wild type release 
levels (Fig. 3.13). These findings confirm that phosphorylated Nur1 is a strong inhibitor 
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of Cdc14 release in early anaphase and that the FEAR network acts to overcome Cdc14 
inhibition by Nur1. However, the incomplete rescue of Cdc14 release in spo12Δ cells by 
Nur1 deletion also suggests that the FEAR network acts at least in part by a mechanism 
other than the inactivation of Nur1. 
 
Figure 3.13 – Preventing Nur1 phosphorylation restores Cdc14 release in a FEAR 
pathway mutant. 
Quantification of Cdc14 release versus spindle length, in spo12Δ, nur1Δ spo12Δ and 
nur1(9A) spo12Δ cells. As previously, Cdc14 release was subdivided into ‘Partial release’ 
and ‘Full release’. The mean and standard deviation from three independent 
experiments is shown. 
 
 
Next, the timing of cell cycle progression was compared between wild 
type, nur1Δ and nur1(9A) strains. Despite the early Cdc14 release in the latter strains, 
the timing of progression through mitosis, as measured by the fractions of cells 
displaying metaphase and anaphase spindles at each time point, was identical to wild 
type (Fig. 3.14). As previously reported, in a spo12Δ background, anaphase was 
extended by around 20 minutes. In this case, nur1Δ or introduction of nur1(9A) led to a 
near complete rescue of the kinetics of cell cycle progression (Fig. 3.14).  
I subsequently investigated whether Nur1 plays a more global role in Cdc14 release or 
else specifically genetically interacts with Spo12. Both the experiments regarding Cdc14 
release and mitotic progression were repeated in a slk19Δ background, defective for 
another protein involved in the FEAR pathway. As anticipated, Cdc14 release was 
delayed (although to a lesser extent than in the spo12Δ background) until later in 
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anaphase, when spindles had reached 5-6 µm, in the slk19Δ deletion alone. Further, a 
partial restoration of early Cdc14 release was observed in nur1Δ slk19Δ, similarly to 
what was observed in spo12Δ cells (Fig. 3.15A). Introduction of nur1Δ into slk19Δ 
background also led to a rescue of the delay in anaphase seen in the latter (Fig. 3.15B).  
These results further confirm that Nur1, specifically in its phosphorylated form, can 
delay mitotic progression. 
 
 
Figure 3.14 – Preventing Nur1 phosphorylation restores timely progression through 
mitotic exit in a FEAR pathway mutant 
Progression through mitosis of in wild type, nur1Δ, nur1(9A), spo12Δ, nur1Δ spo12Δ 
and nur1(9A) spo12Δ was measured by counting percentages of cells displaying 
metaphase (1–3 µm) or anaphase (>3 µm) spindles during synchronous cell cycle 
progression. 
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Figure 3.15 – Nur1 deletion can rescue Cdc14 release and cell cycle progression in a 
second FEAR pathway mutant 
A. Quantification of Cdc14 release versus spindle length, as in Fig. 3.12, in spo12Δ, 
nur1Δ slk19Δ As previously, Cdc14 release was subdivided into ‘Partial release’ and 
‘Full release’. B. Progression through mitosis of the strains above was measured by 
counting percentages of cells displaying metaphase (1–3 µm) or anaphase (>3 µm) 
spindles during synchronous cell cycle progression. 
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3.7 Nur1 inactivation does not compensate for MEN defects 
Inactivation of Nur1, by deletion or mutation of its Cdk phosphorylation sites, 
increases release of Cdc14 in early anaphase and almost completely rescues strains with 
defective FEAR pathway signalling. On the one hand, this could be because phospho-
regulation of Nur1 has a role specific to early anaphase. On the other hand, Nur1 might 
be a general inhibitor of Cdc14 release, at all stages of mitotic exit.  
To differentiate between these two possibilities, we tested whether Nur1 inactivation 
can also compensate for partial loss of MEN signalling. We used conditional 
thermosensitive alleles in two kinases active in the MEN pathway (see section 1.4), 
cdc15-2, and dbf2-2, and asked whether nur1Δ could rescue cell growth at a semi-
permissive temperature with partially defective MEN signalling, as was observed for 
instance in tof2Δ mutants, where Cdc14 release is easier (Waples, Chahwan, 
Ciechonska and Lavoie, 2009). However, it was found that cdc15-2 Δnur1 and dbf2-2 
nur1Δ double mutants died to the same extent as the parental strains cdc15-2, and dbf2-
2, as the temperature increased, whereas Δnur1 strains alone were fully viable at all 
temperatures tested (Fig. 3.16). 
 Thus, Nur1 does not appear to act in late anaphase, when the MEN is controlling 
Cdc14 release. Instead, the function of Nur1 as a Cdc14 inhibitor seems to be restricted 
to early anaphase. This conclusion is consistent with the pattern of Nur1 
phosphorylation during mitotic exit. Nur1 is phosphorylated by Cdk during early 
mitosis, when it counteracts Cdc14 release. In anaphase, Nur1 becomes 
dephosphorylated due to Cdc14 action, thus losing its inhibitory effect on Cdc14.
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Figure 3.16 – Nur1 cannot rescue defective MEN pathway activation 
Nur1 deletion does not reduce the requirement for the MEN. Strains of the indicated 
genotypes were streaked on YPD agar plates and grown at the temperatures shown. 
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3.8 Nur1 may contribute to Cdc14 sequestration by influencing 
Cdk phosphorylation of Net1 
3.8.1 Nur1 and Net1 physically interact 
In order to gain more insight into the mechanism by which Nur1 prevents Cdc14 
release, we examined whether Nur1 physically interacts with proteins involved in the 
control of mitotic exit. In a previous study, it was found that affinity purified fractions 
of Nur1, analysed by mass spectrometry, contained Heh1 and mitotic monopolin, as 
well as a Net1 peptide (Mekhail et al., 2008).  
To confirm the physical interaction between Net1 and Nur1, a co-immunoprecipitation 
experiment was carried out. In strains in which Net1 is tagged with myc and Nur1 with 
Pk, we synchronised cells in G1 and released them to go synchronously through the cell 
cycle. At 15-minute intervals, the interaction of Net1 with Nur1 was monitored by 
immunoprecipitating Net1 from cell extracts using an α-myc antibody. The proteins 
co-immunoprecipitated, with little variation in interaction strength between different 
cell cycle stages (Fig. 3.17). In addition, the strain contained Cdc14 tagged with HA; 
Cdc14 was also detected to be co-immunoprecipitating with Net1 and Nur1 in our 
extracts (Fig. 3.17). While it is currently unknown with which of Net1 and/or Cdc14 
Nur1 makes direct contact, this finding opens the possibility that Nur1 directly 
influences Cdc14 inhibition together with Net1.  
3.8.2 Nur1’s effect on Cdc14 is dependent on Net1’s phosphorylation 
status 
One of the key events during Cdc14 activation early in anaphase is Cdk 
phosphorylation of Net1 on at least six Cdk consensus phosphorylation sites. One 
hypothesis for the mechanistic role of Nur1 in Cdc14 release is therefore that Nur1 
opposes Cdc14 release by influencing the phosphorylation state of Net1. In order to 
start investigating this, I took advantage of the net1-6Cdk allele that lacks these six Cdk 
phosphorylation sites and, as a consequence, delays activation of Cdc14 and causes a 
small delay in mitotic exit. If Nur1’s role in Cdc14 activation is mediated by a 
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counteracting effect on Net1 phosphorylation, then Nur1 inactivation will not be able 
to rescue the mitotic exit delay of net1-6Cdk cells. On the other hand, if Nur1 is acting 
to inhibit Cdc14 in a pathway different from influencing Net1 phosphorylation, then its 
deletion should be able to advance Cdc14 activation in net1-6Cdk cells, in a similar way 
to what was observed in the spo12Δ background. However Nur1 deletion did not 
advance the timing of Cdc14 release or reduce the delay in mitotic exit of net1-
6Cdk cells (Fig. 3.18). This suggests that Nur1 contributes to Cdc14 regulation most 
likely by influencing Cdk phosphorylation of Net1. 
 
Figure 3.17 – Nur1, Net1 and Cdc14 form a complex 
Nur1 interacts with Net1 throughout the cell cycle. Cell extracts were prepared from 
aliquots of a culture passing through a synchronous cell cycle at the indicated times. 
Co-immunoprecipitation of Nur1-Pk with Net1-myc was examined. A strain 
expressing Nur1-Pk but lacking the Net1-myc epitope served as a control. Cell cycle 
progression was monitored by FACS analysis of DNA content; the prevalent cell cycle 
stages are indicated. 
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Figure 3.18 – Nur1’s effect on Cdc14 is dependent on Net1’s phosphorylation status 
A. Progression through mitosis of wild type, nur1Δ, net1-6cdk and nur1Δ net1-
6cdk cells was measured by counting percentages of cells displaying metaphase (1–3 
µm) or anaphase (>3 µm) spindles during synchronous cell cycle progression following 
α-factor arrest and release. B. Quantification of Cdc14 release versus spindle length, 
during the experiment above. 
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3.9 Discussion and conclusions 
3.9.1 Nur1, a novel player in budding yeast mitotic exit 
The paramount importance of Cdc14 in budding yeast mitotic exit has become evident, 
with the list of its targets and functions ever increasing. For instance, its incompletely 
understood role in cytokinesis has recently come into focus, with a range of Cdc14 
targets identified whose dephosphorylation is necessary for completion of this cell cycle 
stage (Kao et al., 2014; Kuilman et al., 2015). Concomitantly, our understanding of the 
regulation of the release and activity of this phosphatase is also deepening.  
At the beginning of this thesis, I set out to further our knowledge of the role of Cdc14 
in rDNA condensation, resolution and segregation. A promising target was recognised 
in the guise of the nuclear rim protein Nur1 – both identified as a Cdc14 target in a 
mass spectrometry screen and with a known role in regulating rDNA repeats. After 
confirming, both in vivo and in vitro, that the protein was a bona fide Cdc14 target, 
dephosphorylated by mid-anaphase, I created a version of Nur1 that, due to being fused 
to the cyclin Clb2, could no longer be dephosphorylated. This fusion led to a reduction 
in viability, as well as a noticeable delay in rDNA segregation, with the persistence of 
anaphase bridges formed by the rDNA repeats – characteristic of mis-segregation and 
chromosomal instability.  
However, upon further investigation, it was revealed that the delay in rDNA 
segregation was in fact due to a higher-level delay in mitotic exit itself. As such, I found 
that fusion of Nur1 to Clb2 caused a delay in Cdc14 release, which was responsible for 
persistence of anaphase spindles, delayed destruction of Clb2 and delayed 
dephosphorylation of Orc6, as well as a lag in accumulation of Sic1. Intriguingly, it also 
resulted in a delay in the metaphase to anaphase transition as measured by Pds1 
destruction and ratio of metaphase/anaphase spindles in synchronous cell cycles. It 
could be that a small amount of Cdc14 needs to be released late in metaphase or early in 
anaphase. Indeed, a role for active Cdc14 in metaphase has been proposed. It has been 
shown to be involved in promoting the dephosphorylation of the kinetochore protein 
Dsn1, possibly promoting chromosome biorientation (Akiyoshi and Biggins, 2010). 
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Further, a function for Cdc14 in keeping Spo12 dephosphorylated and inactive until 
early anaphase has also been proposed (Tomson et al., 2009). Alternatively, Nur1 may 
have functions in metaphase other than regulating Cdc14 release – this could be a 
subject for further studies.  
3.9.2 A relationship between Nur1’s role in mitotic exit and its 
established role in maintenance of genome stability?  
I have established that Nur1 plays an important role in in promoting accurate timing of 
mitotic exit events through regulating Cdc14. However this protein was previously 
characterised as necessary for the maintenance of genome stability and replicative life 
span, important for physically linking the genome to the nuclear membrane – giving it 
an identity as a CLIP (chromosome linkage INM proteins). Are these roles independent 
functions for this protein, or somehow related?  
Interestingly, I found that Nur1-Clb2 fusion increased Unequal Sister Chromatid 
Exchange – thereby causing unequal segregation of the rDNA repeats. Given that it was 
previously reported that nur1Δ also causes an increase in Unequal Sister Chromatid 
Exchange as well as changes in rDNA copy number, it will be interesting to examine 
whether Nur1’s role in tethering the rDNA to the nuclear envelope is somehow 
dependent on its phosphorylation state. It is unknown whether or how the tethering of 
the rDNA changes during the cell cycle, for instance if the tethering is modified or 
maintained during condensation and segregation, or how the rDNA moves relative to 
the nuclear envelope. In fact, Nur1 was previously predicted to be a Cdk-regulated 
nucleocytoplasmic shuttling protein, due to the Cdk site within its putative nuclear 
localisation signal (Kosugi, Hasebe, Tomita and Yanagawa, 2009). This indicates that 
its localisation may well be modified in a cell cycle dependent manner, having possible 
implications both for Cdc14 release and rDNA tethering.  
Having performed a superficial examination of Nur1 localisation throughout the cell 
cycle by immunofluorescence analysis, this was not something I observed. A slight 
enrichment of the immunofluorescence signal at the nuclear envelope was noticed, 
whatever the cell cycle stage, befitting the previously annotated localisation of the 
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protein and its interaction with nucleolar proteins throughout the cell cycle. However 
background signal was very high, so cell cycle dependent modifications in localisation 
cannot be ruled out.    
Related to this, one of the phenotypes reported in net1-1 mutants was a high rate of 
chromosome loss (Shou and Deshaies, 2002) indicating that proteins with a role in 
Cdc14 regulation might more generally play a role in accurate chromosome segregation.  
3.9.3 A dual role for Nur1 in Cdc14 release 
Both deleting Nur1, and making a nur1(9A) mutant, caused Cdc14 to be released both 
earlier and, in the case of the Nur1 deletion, more abruptly than in wild type cells. 
Indeed, in a small proportion of nur1Δ cells Cdc14 was released both into the nucleus 
and cytoplasm in cells with a cytological appearance typical of metaphase rather than 
anaphase, when the spindles had formed but not yet properly started elongating. This 
could indicate that the primary function of phosphorylated Nur1 is to prevent Cdc14 
from being released too early, or too much Cdc14 from being released in the early 
stages of anaphase. This could be rationalised with reference to a quantitative model of 
mitotic exit, in which Cdc14 substrates are thought to be dephosphorylated at a specific 
level of phosphatase activity versus Cdk kinase activity. Thus in very early anaphase, 
phospho-Nur1 makes sure that the levels of Cdc14 are kept low so that it only targets 
the very best substrates.  
The fact that Nur1 deletion or nur1(9A) mutation partly rescue FEAR, but not MEN 
pathway mutants support a role for the dephosphorylation of this protein in early 
anaphase in order to aid Cdc14 release.  
Firstly, upon FEAR pathway activation, a small amount of Cdc14 can be released, 
leading to a low level of active Cdc14 in the cell – enough to dephosphorylate the 
phosphatase’s “early targets”. Following this, Cdc14 can then promote an increase in its 
own activity levels by dephosphorylating Nur1, relieving this second level of inhibition. 
This process would be facilitated due to the concomitant drop in Cdk activity occurring 
as the cells progress through anaphase. This would cause release of higher amounts of 
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the phosphatase, with activity levels necessary for the dephosphorylation of the next 
round of targets. Finally, through the action of this positive feedback loop involving 
Nur1 dephosphorylation, enough Cdc14 would be released for the MEN pathway to be 
activated (Fig. 3.19).  
Whether the dephosphorylation of Nur1 actually stimulates release of Cdc14, or just 
stops Nur1 from inhibiting it, is still an open question. Although I have shown that 
Nur1 interacts with Net1 throughout the cell cycle, the molecular mechanism by which 
phosphorylated Nur1 inhibits Cdc14 release is unclear. Indeed, the molecular 
mechanisms by which the FEAR and MEN pathways cause Cdc14 to be released from 
Net1, or indeed how Net1 sequesters Cdc14, also remain unknown. It is possible that 
Nur1 is influencing the interaction between Net1 and Cdc14, causing Net1 to have a 
tighter hold, or perhaps Nur1 itself contributes to sequestering the phosphatase. Upon 
dephosphorylation, the interaction would then be modified. 
Thus it seems likely that Nur1 has a dual role in Cdc14 release, both preventing it when 
phosphorylated and stimulating it when dephosphorylated. In fact, there are several 
other proteins that may have similar dual roles towards Cdc14. For instance it has been 
shown that Tof2 restrains Cdc14 release early in anaphase (when the FEAR pathway is 
active), and activates it late in anaphase (when the MEN pathway is active) (Waples et 
al., 2009). Similarly, it is thought that Slk19, although activating Cdc14 release as part of 
the FEAR pathway actually prevents exit of Cdc14 from the nucleus, via a separate 
mechanism, until the MEN is active (Faust et al., 2013). Finally, this is not the only 
example of Cdc14 regulating its own release – as mentioned previously, it is thought 
that the phosphorylation state of Spo12 influences its FEAR pathway role, with Cdc14 
maintaining it in a dephosphorylated and inactive state until early anaphase, when it is 
activated by Cdk phosphorylation (Tomson et al., 2009).  
A robust positive feedback loop, in which Nur1 prevents Cdc14 from being released 
until dephosphorylated, but stimulates Cdc14 release upon this event, could explain 
how Cdc14 release is maintained between its initial activation by the FEAR pathway 
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and the sustained release caused by the MEN pathway. In this fashion, Nur1 could form 
a bridge between the two characterised Cdc14 release pathways (Fig. 3.19).  
 
Figure 3.19 – Nur1 establishes a positive feedback loop to promote Cdc14 release in 
early anaphase.  
At the metaphase to anaphase transition, Cdc14 starts to be released following APC-
mediated securin destruction, which liberates separase to downregulate PP2ACdc55. This 
allows Cdk to phosphorylate Net1 to initiate Cdc14 release. At the same time Cdk 
activity is in decline, thus removing the original impetus for Cdc14 release. To 
counteract this, Nur1 is dephosphorylated by early released Cdc14. This turns off 
Nur1’s ability to inhibit Cdc14 and thus helps to sustain and augment Cdc14 release 
until the MEN pathway becomes active to maintain Cdc14 release while Cdk activity is 
further downregulated. 
 
3.9.4 Future perspectives 
On the on one hand, there is a requirement to deepen our understanding of the role of 
Nur1, and Net1, beyond mitotic exit, notably in regulating the accuracy of chromosome 
partitioning. Further, the targets of Cdc14 necessary for the accurate condensation and 
segregation of the rDNA still remain to be identified. 
In fact, how the genome, a spatially constricted entity, tethered to the nuclear envelope, 
organised into higher order structures, with a large amount of proteins bound to it, 
manages to first replicate, then condense, and finally accurately segregate to opposite 
parts of the cell is still incompletely understood, as is how all of this is regulated in a cell 
cycle dependent manner. As such, the relationships between the RENT complex and 
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Nur1 phosphorylation, and chromosome segregation and genome organisation, remain 
to be examined.  
On the other hand, although the genetics behind the regulation of Cdc14 release are 
well-understood, the molecular mechanisms behind this are still unclear. As such, the 
next step in understanding how this process works is to work out, mechanistically, how 
phosphorylation of Net1 by the FEAR and MEN promotes Cdc14 release, and further, 
how Nur1 contributes to this process.  
In this chapter, I have focused on the role of phosphatases in budding yeast mitotic exit, 
specifically giving new insights into the regulation of Cdc14 activity in this cell cycle 
phase. The process of mitotic exit is already fairly well understood, and the importance 
of phosphatase activity, and the regulation of this activity have been established.  
However, what is less well understood is the role of Cdk-opposing phosphatases in 
other cell cycle phases. In particular, whether such phosphatases have a role in 
controlling the ordering of Cdk substrate phosphorylation in interphase, and by doing 
so the ordering of cell cycle events such as S phase or G2, is unknown.  
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Chapter 4. Results: A role for Cdk-opposing 
phosphatases in budding yeast interphase 
As discussed in Chapter 1, there are three main Cdk-opposing phosphatases in budding 
yeast: Cdc14, PP1 and PP2A, the roles of the latter two being diversified by association 
with a variety of regulatory subunits. Extrapolating from the established role of Cdc14 
in controlling the ordered dephosphorylation of Cdk substrates in a quantitative 
manner during budding yeast mitotic, it can be postulated that in a similar manner, 
Cdk-opposing phosphatase activity could be controlling ordered Cdk substrate 
phosphorylation during interphase. As during mitotic exit, we can hypothesise that the 
timing of substrate phosphorylation during interphase would be controlled by the ratio 
of Cdk activity to Cdk-opposing phosphatase activity. Therefore the combination of 
rising Cdk activity, along with constant (or declining) Cdk-opposing phosphatase 
activity, would determine the order in which substrates are phosphorylated. Whether 
any, all, or none of these three phosphatases are indeed playing such a role was the 
second question I aimed to address.  
4.1 Strategic approach for examining the importance of 
phosphatase activity in interphase 
In order to look at the role of phosphatases in interphase, my first approach was to 
remove phosphatase activity, and the second to have a biochemical and/or phenotypic 
read-out for the consequences of this removal.  
4.1.1 Removing phosphatase activity 
 Cdc14 is a single-subunit phosphatase, thus removing its activity can simply rely on 
the use of temperature-sensitive yeast strains, in which Cdc14 is active at the permissive 
temperature of 25°C and inactivated at the restrictive temperature of 35.5°C. Similarly, 
although PP1 is a multi-subunit phosphatase, it only has one catalytic subunit, Glc7, 
which can also be inactivated through the use of temperature sensitive alleles. 
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However, creating a strain lacking PP2A activity is more challenging. Firstly, this 
protein is a multi-subunit phosphatase, composed of a scaffold subunit, a catalytic 
subunit and a regulatory subunit. Moreover, the S. cerevisiae genome encodes two near-
identical catalytic subunits, Pph21 and Pph22, each of which provides about 50% of the 
PP2A activity in the cell, and either of which can compensate for deletion of the other 
(Jiang, 2006; Sneddon, Cohen and Stark, 1990). In fact, even deletion of both subunits 
together does not completely abrogate PP2A activity, as the PP2A-like phosphatase 
Pph3, which is structurally similar to Pph21 and Pph22, is thought to be able to partly 
compensate for their absence (Jiang, 2006). In order to completely remove PP2A 
catalytic activity it is therefore necessary to use a strain in which both Pph22 and Pph3 
are deleted, combined with a temperature sensitive allele of Pph21.  However, cell 
viability and growth is severely compromised in this strain, and in fact these cells were 
unable to release from a G1, α-factor induced, arrest, at restrictive temperature. 
Given these limitations, I decided to focus on the role of PP2ACdc55. As discussed in 
Chapter 1, this version of the phosphatase is known to play a variety of roles in the S. 
cerevisiae cell cycle. Further, it is highly active in interphase, and in other eukaryotic 
systems, its homologs have been shown to play a negative role in mitotic entry. Further, 
a role for PP2ARts1 has so far only been confirmed in very early interphase, and in cell 
size regulation. We can therefore postulate that PP2ACdc55 is the version of this 
phosphatase most likely to be implicated in cell cycle progression.   
Deletion of Cdc55 is not lethal, however causes severe growth defects, due to its role in 
opposing Swe1 activity in interphase. As discussed in Chapter 1, this is due to the fact 
that Cdc55 is required for timely progression through the G2/M transition. In fact, as I 
was interested in understanding roles of PP2A in interphase other than its previously 
established role at the G2/M transition, I created a double deletion strain lacking both 
Cdc55 and Swe1, which restored cell viability and virtually normal cell cycle 
progression, as previously reported (Harvey et al., 2011; Yang, Jiang, Gentry and 
Hallberg, 2000). As such, swe1Δ and swe1Δ cdc55Δ cells release from an α-factor 
induced G1 arrest and carry out DNA replication with identical timing, as monitored 
by FACS analysis of DNA content (Fig. 4.1A). Further, they enter metaphase and then 
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anaphase together, as monitored by counting metaphase spindles (1–3 µm) and 
anaphase spindles (>3 µm) as cells progressed through the cell cycle, although swe1Δ 
cdc55Δ cells then have a slight delay in progression through anaphase (Fig. 4.1B).  
Therefore using a swe1Δ cdc55Δ strain, with a swe1Δ strain as a control, seems like an 
appropriate model to study the role of PP2ACdc55 in interphase.  
 
Figure 4.1 – swe1Δ and swe1Δ cdc55Δ strains progress through interphase and enter 
mitosis with identical timings 
Cell cycle progression of swe1Δ and swe1Δ cdc55Δ cells was monitored A. by FACS 
analysis of DNA content, and B. by counting percentages of cells displaying metaphase 
(1–3 µm) or anaphase (>3 µm) spindles during synchronous cell cycle progression 
following α-factor arrest and release. 
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4.1.2 Measuring changes in Cdk phosphorylation levels 
Once phosphatase activity has been removed, there arises a need to directly measure 
what happens to Cdk substrate phosphorylation in interphase. Cells can be 
synchronised in G1 by α-factor treatment, released to progress through the cell cycle 
synchronously and protein extracts prepared at intervals. Using these extracts, global 
levels of Cdk phosphorylation can be monitored by carrying out a Western blot using a 
range of antibodies against phosphorylated Cdk sites, which recognise phosphorylation 
of numerous Cdk phosphorylation sites. In addition, by tagging specific proteins with 
an epitope tag, these proteins being usually phosphorylated in interphase, changes in 
their timing of phosphorylation may be observed by monitoring mobility shifts on an 
SDS-page gel.  
4.2 Identification of interphase Cdk targets 
4.2.1 A SILAC screen to identify G2/M Cdk targets 
Initially, I hypothesised that Cdk-phosphatase activity would be most important at the 
later stages of interphase, and more specifically in G2, where Cdk activity is already 
high but cells have not yet formed spindles. In order to identify Cdk targets that are 
phosphorylated in metaphase but not in G2, I decided to perform a SILAC (Stable 
Isotope Labelling in Culture) screen, in which I compared G2 Cdk phosphorylation to 
Metaphase Cdk phosphorylation (Gruhler et al., 2005). Using this technique, in which a 
culture grown in the presence of heavy isotopes of lysine and arginine and a culture 
grown in the presence of light isotopes of arginine and lysine were combined, I was able 
to directly compare phosphorylated peptides between G2 and metaphase.   
In order to compare phosphorylation in a “natural” cell cycle (i.e. without arresting 
cells with Nocodazole, for instance, which leads to artificially high levels of Cdk 
phosphorylation), cells (grown in either “light” or “heavy” media) were synchronised in 
G1 by α-factor pheromone arrest, released to progress synchronously through the cell 
cycle and samples taken at the time when the majority of the cells pass through G2 and 
M phase. To determine when these phases are happening, three repeats of this arrest 
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and release experiment were carried out before performing the SILAC experiment itself. 
G2 was taken to be after cells had duplicated their DNA (by measuring DNA content by 
FACS analysis), and 5 minutes before the start of spindle formation, and metaphase 
when metaphase spindles reached their peak of 70-80%, which was exactly 20 minutes 
after that (Fig. 4.2A-B).  
For the SILAC experiment itself, both cultures (heavy and light) were synchronized in 
G1 using α-factor, at a 20-minute interval, and released, at a 20-minute interval, 150 
minutes after the arrest (therefore, respectively, 150 minutes, and 170 minutes after the 
beginning of the experiment) (Fig. 4.2C). The cells were harvested together 45 minutes 
after the release of the second culture (therefore, 65 minutes after the release of the first 
culture) at which point identical amounts of cells from the light and heavy cultures 
were combined, and processed for mass spectrometry analysis. The experiment was 
repeated twice, once with the heavy culture in G2 and light in M, and the second time 
vice-versa. An asynchronous control was also harvested.  
Chapter 4. Results 
 
 108 
 
 
Figure 4.2 – Design of a SILAC screen to compare G2 vs. M Cdk phosphorylation  
Cell cycle progression of a wild type strain in YNB media was monitored A. by FACS 
analysis of DNA content, and B. by counting percentages of cells displaying metaphase 
(1–3 µm) or anaphase (>3 µm) spindles during synchronous cell cycle progression 
following α-factor arrest and release. C. In order to perform a SILAC screen, cells were 
grown in media with either heavy or light Lys/Arg isotopes, arrested in G1 with a 20 
minute interval and harvested together and combined, before being processed and sent 
for mass spectrometry analysis. 
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The “G2-Heavy/M-Light” and “G2-Light/M heavy” experiments were correlated, and 
only phosphorylated peptides found to be enriched in metaphase in both experiments 
were taken into account in the final analysis of the results. The peptides were plotted 
graphically, correlating the ratio of heavy versus light for each peptide identified, 
between the two experiments, giving rise to a scatter plot in which peptides enriched in 
metaphase can be visualised. In total, around 300 phosphopeptides were found to 
enriched in metaphase (Fig. 4.3). Of these around 100 had Cdk consensus sites, of 
which 30 were full S/TPxR/K Cdk consensus sites (Fig. 4.3).  
These 100 or so peptides covered a variety of proteins, a handful of which were chosen 
for further study. Of the peptides identified, I chose ones that had been identified at 
least once in all three experiments, had been identified more than once in at least one 
experiment and were not enriched in heavy or light samples in the asynchronous 
control. Further, for proteins in which several peptides had been identified, I chose only 
to study those in which the majority of the identified phospho-peptides were enriched 
in metaphase. Proteins chosen for further study, and their previously known functions, 
are summed up in Table 4.1.  
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Figure 4.3 – Metaphase Cdk targets identified by SILAC 
Two reverse SILAC experiments  (heavy=G2 and light=M, and vice-versa) were 
correlated to determine which peptides were enriched in metaphase (rectangle in top-
left quadrant (A-B). Cdk phosphorylated phosphopeptides were identified, on both full 
(A) and minimal Cdk sites, (B), and the identity of those enriched in metaphase was 
determined (C). 
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Table 4.1 – Metaphase Cdk targets identified in the SILAC screen and their 
previously characterised roles 
 
I subsequently carried out cell cycle Western blot analysis on these proteins, to examine 
whether I could identify the timing of their phosphorylation by examining mobility 
shifts by SDS-Page electrophoresis. Cells were synchronised in G1 by α-factor 
treatment and released to proceed through the cell cycle synchronously. Unfortunately, 
for all of the above proteins, either a mobility shift was not identified, it did not vary in 
a cell cycle dependent manner, or the timing of phosphorylation was unclear due to the 
presence of too many bands. 
Protein
Number of 
unique 
phosphopeptides 
(enriched in M)
Number of 
full CDK 
sites
Known 
CDK 
target
Function
Spa2 8 2 Yes Polarised growth, cytokinesis
Apc9 1 1 Yes APC complex
Bik1 2 (same site) 1 No
Important for 
positioning of the 
spindle (+TIP 
protein)
Bud4 3 0 Yes Cytokinesis
Net1 7 1 Yes FEAR complex
Src1 2 0 Yes
Tethering of 
telomeres/rDNA to 
nuclear envelope 
and sister 
chromatid 
segregation
Hsl1 1 1 No
Cell cycle kinase, 
important for Swe1 
degradation
Muk1 1 1 No Unknown
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4.2.2 Identifying Cdk targets – a candidate approach 
This led me to a second, more biased, approach in order to identify interphase Cdk 
targets. I began a candidate approach, in which I searched through the literature for 
proteins that were known Cdk targets with known phospho-shifts, and phosphorylated 
with various timings in interphase of the cell cycle. A summary of the proteins chosen 
and their timing of phosphorylation is presented in Table 4.2.  
 
Table 4.2 – Candidate interphase Cdk targets 
Candidate interphase Cdk targets were identified from searching the available literature 
and published data. 
 
After having chosen these target proteins, I then proceeded to determine whether Cdk 
phosphorylation was altered in the absence of phosphatase activity, beginning with 
PP2ACdc55.  
 
 
 
 
 
Protein Phosphorylation timing
Ndd1 Phosphorylated in S phase, hyperphosphorylated in metaphase
Sli15 Slowly phosphorylated between S and G2
Ask1 G1/S
Swi5 Metaphase (but transcriptionally regulated)
Ase1 Phosphorylated in S phase, hyperphosphorylated in metaphase
Mms4 Phosphorylated in metaphase
Acm1 G1/S - phosphorylation controls stability
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4.3 Removing PP2ACdc55 activity leads to advanced 
phosphorylation of Cdk targets throughout interphase 
4.3.1 Advanced phosphorylation of Ndd1, a G2/M phase Cdk target 
Ndd1, a transcription factor important for the transcription of the “Clb2 cluster” of 
genes, is phosphorylated in G2/M. This phosphorylation is needed for the association 
of the protein with its binding partner Fkh2, leading to binding to DNA and 
transcription of target genes (Reynolds et al., 2003; Darieva et al., 2003). Ndd1 is vital 
for mitosis, controlling the transcription of 30 or so genes including Clb2 itself, as well 
as many other proteins involved in mitotic progression and cytokinesis (Loy, Lydall 
and Surana, 1999; Pic-Taylor, Darieva, Morgan and Sharrocks, 2004).  
Ndd1 phosphorylation was monitored by mobility shifts on a Western blot in a 
synchronous cell cycle experiment, comparing swe1Δ and swe1Δ cdc55Δ cells. 
Phosphorylation of Ndd1 began earlier and was more extensive in the absence of Cdc55. 
Lower mobility bands were observed approximately 30-40 minutes after release from 
G1 in the absence of Cdc55; when the cells were still in S phase according to FACS 
analysis of DNA content. In contrast, slower migrating bands only appeared 50 minutes 
after release when Cdc55 was present in the cells, corresponding to the G2/M transition 
according to previous experiments (Fig. 4.1), and after the completion of S phase, 
according to the FACS profile. The intensity of the slower migrating bands was also 
increased in the swe1Δ cdc55Δ background, indicating a higher proportion of the 
phosphorylated form of the protein as compared to swe1Δ alone (Fig. 4.4).  
As mentioned above, Ndd1 is important for transcription of Clb2, which it does when 
phosphorylated by Cdk. This suggests that advanced Ndd1 phosphorylation could lead 
to earlier transcription of Clb2. Clb2 levels were viewed by western blot in the 
experiment in Figure 4.4, comparing swe1Δ and swe1Δ cdc55Δ in a synchronous cell 
cycle. No difference in timing of appearance of the protein was apparent between the 
two strains, although Clb2 persisted for longer in the absence of Cdc55 (Fig. 4.5).   
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Figure 4.4 – Phosphorylation of Ndd1 is advanced in the absence of Cdc55 
A. Ndd1 phosphorylation was monitored using an anti-HA antibody at regular 
intervals during synchronous cell cycle progression following α-factor arrest and 
release, in swe1Δ and swe1Δ cdc55Δ strains. Tubulin was used as a loading control B. 
Cell cycle progression was monitored by FACS analysis of DNA content.  
 
 
 
 
 
 
 
 
Chapter 4. Results 
 
 116 
 
Figure 4.5 – Clb2 is not expressed earlier in swe1Δ cdc55Δ than in swe1Δ  
A. Clb2 levels were monitored using an anti-Clb2 antibody at regular intervals during 
synchronous cell cycle progression following α-factor arrest and release in swe1Δ and 
swe1Δ cdc55Δ strains. Tubulin was used as a loading control B. Cell cycle progression 
was monitored by FACS analysis of DNA content.  
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Phosphorylation of a G2/M phase Cdk target is advanced in the absence of Cdc55. Is 
the same true for proteins phosphorylated earlier in interphase? 
4.3.2 Advanced phosphorylation of Sli15, an S/G2 phase Cdk target 
The next Cdk target to be examined was Sli15, a member of the Chromosome 
Passenger Complex (CPC). In a normal cell cycle, Sli15 needs to be phosphorylated 
before metaphase to stop the CPC from binding to microtubules, and for the CPC to be 
retained at the centromere. It is usually phosphorylated by Cdk in late S phase, and can 
also be phosphorylated by Ipl1 (Widlund et al., 2006; Mirchenko and Uhlmann, 2010).  
In similar synchronous cell cycle experiments as performed previously, it was observed 
that phosphorylation of Sli15, as monitored by mobility shifts on a Western blot, was 
advanced by around 10-15 minutes in swe1Δ cdc55Δ as compared to swe1Δ. As such, a 
slower migrating band was clearly already visible 10-20 minutes after release from G1 
in the absence of Cdc55 (before S phase according to FACS analysis of the DNA 
content), whilst this was not the case until 20-30 minutes after release (during S phase) 
in the presence of Cdc55. However, in both cases, full phosphorylation of the protein – 
appearance of a second slower migrating band above the first – was not reached until 
40-50 minutes after release from G1, after DNA replication was already completed (Fig. 
4.6).  
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Figure 4.6 – Phosphorylation of Sli15 is advanced in the absence of Cdc55 
A. Sli15 phosphorylation was monitored using an anti-HA antibody at regular intervals 
during synchronous cell cycle progression following α-factor arrest and release, in 
swe1Δ and swe1Δ cdc55Δ strains. Tubulin was used as a loading control B. Cell cycle 
progression was monitored by FACS analysis of DNA content.  
 
4.3.3 Advanced phosphorylation of Acm1, a G1/S phase Cdk target 
To check phosphorylation can also be advanced in very early interphase, for proteins 
phosphorylated by Cdk in complex with Cln-type cyclins rather than Clb-type Cyclins, 
the timing of phosphorylation of Acm1 was investigated. Acm1, a stoichiometric 
inhibitor of APCCdh1, is usually phosphorylated by Cdk in G1/S, which phosphorylation 
event directly controls the stability of the protein (Hall et al., 2008; Ostapenko, Burton, 
Wang and Solomon, 2008). Thus the abundance of the protein in interphase can be 
taken as an indirect readout for phosphorylation of the protein.   
The abundance of Acm1 in interphase was quantified in a synchronous cell cycle 
experiment relating Acm1 levels to Tubulin levels by Western blot, again comparing 
swe1Δ cdc55Δ to swe1Δ cells (Fig. 4.7A-B). Acm1 band intensity was significantly 
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higher in early interphase (before DNA replication) in the absence of Cdc55, a strong 
indication that Acm1 must already be phosphorylated at this time (Fig. 4.7C).  
Figure 4.7 – Phosphorylation of Acm1 is advanced in the absence of Cdc55 
A. Acm1 abundance was monitored using an anti-HA antibody at regular intervals 
during synchronous cell cycle progression following α-factor arrest and release, in 
swe1Δ and swe1Δ cdc55Δ strains. Tubulin was used as a loading control B. Cell cycle 
progression was monitored by FACS analysis of DNA content. C. Acm1 abundance was 
quantified at each time-point relative to the abundance of tubulin; pixel intensity was 
measured from ImageQuant images analysed in ImageJ, before signal saturation.  
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4.4 Removing PP2ACdc55 activity leads to a global increase in 
interphase Cdk phosphorylation 
Given the identification of three specific Cdk targets whose phosphorylation was 
altered in the absence of PP2ACdc55, I examined whether global Cdk phosphorylation 
levels were affected by the absence of this phosphatase. swe1Δ and swe1Δ cdc55Δ cells 
were synchronised by α-factor treatment and released to proceed through the cell cycle 
(in two separate experiments) with protein extracts prepared at 10 minute intervals. 
These were run on SDS-Page gels, which were then probed with antibodies against 
phosphorylated full or minimal Cdk consensus sites; using anti-pSPxR/K, anti-pSP and 
anti-pTP antibodies. 
Global Cdk phosphorylation, both on serines and on threonines, was increased 
throughout the cell cycle in the absence of Cdc55. The pattern of phosphorylation 
varied depending on the antibody used, however in all cases this increase was observed. 
Strikingly, the increase is observable even in the G1-arrested state, with several bands 
being more apparent in the absence of Cdc55, even this early in the cell cycle, with very 
low Cdk activity (Fig. 4.8, arrows). This is also true later in the cell cycle, as the cells 
progress through mitosis. Interestingly, the increase in levels of phosphorylation seems 
more dramatic when monitoring threonine, rather than serine, phosphorylation, 
however at this stage it is not clear whether this could be due to different antibody 
sensitivities/specificities.  
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Figure 4.8 – Global Cdk phosphorylation levels are increased in the absence of 
PP2ACdc55 
Cdk phosphorylation levels were monitored using various anti-phospho-Cdk sites 
antibodies at regular intervals during synchronous cell cycle progression following α-
factor arrest and release. Tubulin was used as a loading control.  
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4.5 Absence of PP2ACdc55 is insufficient to allow entry into 
mitosis with reduced levels of Cdk activity 
From the previous results, we can conclude that PP2ACdc55 regulates protein 
phosphorylation in interphase. Does this have any phenotypic consequences for cells? 
In the first instance, it has already been noted that spindle formation does not occur 
any earlier in swe1Δ cdc55Δ than it does in swe1Δ cells alone, indicating that there 
seems to be no strong need for PP2ACdc55 in order to prevent too early mitotic entry (Fig. 
4.1). However, this was in an unperturbed cell cycle, where Cdk activity is naturally 
high, and small differences in timing of spindle formation might be hard to spot. I 
therefore decided to examine whether in the presence of lower than usual Cdk activity, 
in a G2-arrested state, cells can proceed into metaphase if PP2ACdc55 activity is also 
removed (with the rationale that removing phosphatase activity would restore the 
correct kinase/phosphatase ratio for the G2/M transition to occur). 
Two ways of arresting cells in G2 were tested. Firstly, using a clb1Δ, clb3Δ, clb4Δ, clb2-ts 
strain at restrictive temperature, where mitotic cyclins are absent, causing cells to arrest 
before mitotic entry (Amon, Tyers, Futcher and Nasmyth, 1993). Secondly, I used the 
Shokat allele of Cdc28  (cdc28-as1) in which Cdk activity can be modulated by adding 
rising concentrations of the inhibitor 1NM-PP1. Cells can be arrested either at the G1/S 
transition, with high concentrations of inhibitor, or at the G2/M transition, with low 
concentrations of inhibitor (Shokat et al., 2000).      
In the first case, clb1Δ clb3Δ clb4Δ clb2-ts were combined with either swe1Δ or swe1Δ 
and cdc55Δ. Cells were transferred to restrictive temperature upon release from G1 and 
spindle formation and DNA replication was monitored.  Interestingly, all clb1Δ clb3Δ 
clb4Δ clb2-ts swe1Δ cells escaped the arrest and formed spindles, however clb1Δ clb3Δ 
clb4Δ clb2-ts swe1Δ cdc55Δ cells did not – perhaps the cell cycle is too compromised in 
this situation.   
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Cells with cdc28as-1 combined with either swe1Δ or swe1Δ and cdc55Δ were arrested 
either in G1 or G2 depending on the concentration of inhibitor used, and neither 
displayed any sign of spindle formation even 3 hours after release from G1 (Fig. 4.9).  
 
Figure 4.9 – cdc28as-1 swe1Δ or cdc28as-1 swe1Δ cdc55Δ arrest at the same cell cycle 
stage  
Cell cycle stage was monitored by FACS analysis of DNA content in cdc28as-1 swe1Δ or 
cdc28as-1 swe1Δ cdc55Δ cells in the presence of concentrations of inhibitor 1-NmPP1 
varying from 100 nm to 2 µm, 3 hours after release from an α-factor induced G1 arrest.  
 
From these experiments, we can conclude that deletion of Cdc55 is insufficient to allow 
for mitotic entry with G2 levels of Cdk activity.  
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4.6 PP2ACdc55 preferentially opposes Cdk phosphorylation on 
threonines 
4.6.1 A SILAC screen comparing interphase Cdk phosphorylation 
between swe1Δ and swe1Δ cdc55Δ  
To further understand the role of PP2ACdc55 in opposing Cdk phosphorylation in 
interphase, from a more global point of view rather than focusing on specific Cdk 
targets, a second SILAC screen was carried out. In this screen, Cdk phosphorylation 
was compared between swe1Δ and swe1Δ cdc55Δ at different points in interphase. Cells 
of both genotypes were synchronised in G1 using α-factor. After the cells were 
determined to be fully arrested, the first SILAC sample was taken, mixing equal 
amounts of both cultures. The cultures were then released to progress through the cell 
cycle and two further samples were taken for SILAC analysis, respectively during mid-S 
phase, and G2. The timing of mid-S phase and G2 was determined in test experiments 
by monitoring DNA content by FACS analysis and formation of spindles by 
immunofluorescence, with S phase being when the DNA content was between 1C and 
2C, and G2 when the DNA had fully replicated but the mitotic spindle had yet to form, 
as in the previous SILAC experiment. Each sample was confirmed to have been taken at 
the correct time (by the same measures) before samples were submitted for SILAC 
analysis. Each experiment was performed twice, reversing the “Heavy” and “Light” 
labelling between the swe1Δ and swe1Δ cdc55Δ.   
In the two repeats of the experiment, and over the three time-points, a total of 5307 
phosphosites were identified, with 4589 being quantified, at a phosphopeptide 
enrichment efficiency of 66.6 %. 
At each time point, relative phosphopeptide abundance (ratio of heavy/light versions of 
each identified phosphopeptide) was quantified. Over all of the sample mixes, it was 
found that around 12-20% of all phosphopeptides were enriched in the swe1Δ cdc55Δ 
sample compared to the swe1Δ, whether heavy or light, and, vice-versa, around 2.5-5% 
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of phosphopeptides were enriched in the swe1Δ sample as compared to the swe1Δ 
cdc55Δ sample.  
The two repeats of the experiments were then correlated to provide further statistical 
significance in determining whether Cdk-motif containing phosphopeptides were 
enriched in either the presence or absence of phosphatase activity. Examining scatter 
plots of these correlations, it is immediately apparent that Cdk-containing 
phosphopeptides, both when looking at full Cdk consensus site motifs (pS/pTPxR/K) 
and minimal Cdk consensus site motifs (pS/sTP) appear to be enriched in the absence 
of PP2ACdc55 phosphatase activity, at all cell cycle stages (top-left quadrant of each 
scatter plot, Fig. 4.10). For further details and the results of each individual repeat (non-
correlated) see Appendix 6.1 (Fig. 6.2).  
In order to control for the quality and accuracy of the results, and to counter for any 
bias introduced by the labelling itself, control SILAC experiments were performed in 
which, at each time point (G1/S/G2), swe1Δ vs. swe1Δ (heavy/light) and swe1Δ cdc55Δ 
vs. swe1Δ cdc55Δ (heavy/light) were compared. For the overwhelming majority of 
peptides (97-99%), no significant variation in ratio was observed in the control set of 
experiments (see Appendix 6.1, Fig. 6.1).  
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Figure 4.10 – Cdk-motif containing phospho-peptides are enriched in the absence of 
PP2ACdc55 activity 
C 
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(Figure 4.10 continued) Correlation of the ratio of heavy/light Cdk-containing 
phospho-peptides between swe1Δ cdc55Δ and swe1Δ when the latter is “heavy” and the 
former is “light” (Experiment A) and vice-versa (Experiment B), in G1 (A.), S (B.) and 
G2 (C.).  Phosphopeptides significantly enriched in the absence of phosphatase activity 
are situated in the top-left quadrant.  
 
 
 
The specific identity of the Cdk-phosphorylated peptides is also of interest. The 
peptides were first examined to determine whether Cdk-phosphorylated peptides 
belonging to Acm1, Sli15 or Ndd1 had been detected in any of the experiments. One 
Cdk phosphorylated Acm1 peptide was identified in S and G2 but not in G1, with the 
phosphorylation site on S31, consensus pSPSK. It was not enriched in the absence of 
Cdc55 activity. In the case of Sli15, five Cdk phosphorylated sites were detected in total 
in the three experiments – two in G1, four in S and all five in G2, consistent with a 
gradual increase in phosphorylation of the protein as the cells progress through 
interphase. Four contained a minimal SP site, and one a full SPVR consensus site. Of 
these, one was slightly enriched in the absence of phosphatase activity, and the others 
had more stochastic behaviour – enriched in one repeat of the experiment and not the 
other, for instance.  Finally, four Ndd1 phospho-peptides were identified, detected only 
in S phase and G2. Three of these were clearly enriched in swe1Δ cdc55Δ in both repeats 
of the experiment (Fig. 4.11). Of the four identified phospho-peptides, three were 
phosphorylated on a minimal TP consensus site and one on a minimal SP consensus 
site. Of the three phospho-peptides enriched in the absence of Cdc55, two were 
threonine phosphorylated.  
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Figure 4.11 – Cdk phosphorylation of Ndd1 on three residues is enriched in the 
absence of Cdc55 
Correlation of the ratio of heavy/light phospho-peptides between swe1Δ cdc55Δ and 
swe1Δ when the latter is “heavy” and the former is “light” and vice-versa, in S (A.) and 
G2 (B.).  Phosphopeptides significantly enriched in the absence of phosphatase activity 
are situated in the top-left quadrant, and Ndd1 peptides are highlighted.  
A 
A Ndd1 phospho-peptides 
Ndd1 phospho-peptides 
B 
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4.6.2 Cdk phosphorylation on threonines is enriched in the absence of 
PP2ACdc55 activity 
In order to determine, in an unbiased manner, which types of phosphopeptides were 
enriched at each particular time point, a 2D annotation enrichment analysis was carried 
out (Cox and Mann, 2012). Using this method, respectively, 23 and, 31 and 32 different 
phosphopeptide “categories” were found to be enriched in the G1, S, and G2 samples, 
with a p value of <0.02. These categories ranged from specific kinase motifs, to peptides 
with a certain positive or negative charge, to protein binding motifs. Of specific interest 
are the different types of Cdk kinase motif. These were divided into 6 different and 
somewhat overlapping categories (all of which were identified in the 2D annotation 
enrichment analysis), not only separating minimal Cdk sites from full Cdk sites but also 
serine phosphorylation from threonine phosphorylation. These Cdk motifs are detailed 
in Table 4.3, as well as the total amount of phosphopeptides to be found within each 
category at each time point (added up over the six experiments).  
 
 
Table 4.3 – Cdk motif containing phosphopeptides are enriched throughout 
interphase 
Cdk motifs can be subdivided into full and minimal Cdk motifs, and whether the 
phosphorylated amino acid is a serine or a threonine. Full Cdk sites are much less 
abundant than minimal ones, particularly threonine-phosphorylated full sites.  
 
 
 
 
 
 
G1 S G2
Full$Cdk$Site pS/TPxR/k 125 145 155
Minimal$Cdk$Site pS/TP 914 846 851
Full$Cdk$Site$_pS$ pSPxR/K 106 121 127
Full$Cdk$Site$_pT pTPxR/K 19 24 28
Minimal$Cdk$Site_pS pSP 691 640 643
Minimal$Cdk$Site_pT pTP 223 206 208
Total*Amount*of*PhosphopeptidesCategory Motif
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From a superficial analysis of phosphopeptide abundance within each category, it can 
be concluded that serine phosphorylation by Cdk is more common than threonine 
phosphorylation, as has been previously observed (Kuilman et al., 2015). In fact, 
threonines make up 15-18% of phosphorylated full Cdk sites, and around 25% of 
minimal Cdk sites (Fig., 4.12).  
 
Figure 4.12 – Threonines make up ~25% of total Cdk-phosphorylated sites  
Phospho-Threonines as a proportion of phosphorylated Cdk consensus sites, either full 
(A.) or minimal (B.), in G1, S and G2.  
 
Next, we examined whether any in particular of these categories of Cdk sites was 
enriched in swe1Δ cdc55Δ compared to swe1Δ alone. Again, the ratio of heavy/light 
phosphopeptides in each category was correlated between the two strains, and plotted 
graphically as in Figure 4.10.  Interestingly, Cdk substrate phosphorylation, although 
more so on minimal Cdk than full Cdk sites, appears mildly enriched in the absence of 
phosphatase activity. Strikingly, however, when Cdk phosphorylation is separated into 
serine versus threonine phosphorylation, this enrichment can in fact be accounted for 
by an increase in the phosphorylation of threonines. This is true for phosphopeptides 
with both full and minimal pTP Cdk phosphosites, even more strikingly so for the 
latter than the former (Fig. 4.13). Further, phosphorylation of threonines as a 
proportion of phosphorylation on full Cdk sites increases slightly as the cells progress 
through interphase (Fig. 4.12).  To confirm the validity of this result, we examined 
whether in the control experiment, pTP phosphopeptides displayed any variation in 
ratio – this was not the case (see Appendix 6.1).  
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This indicates that PP2ACdc55 is preferentially working to dephosphorylate threonine-
containing Cdk phospho-proteins during interphase, possibly having a higher affinity 
for full Cdk sites than minimal Cdk sites.  
Of further interest is the fact that the Aurora kinase motif was also identified to be 
enriched in the SILAC experiment, although only in the S phase and G2 experiments. 
However, in contrast to what was observed with Cdk motifs, Aurora kinase motif 
containing peptides (of which respectively 49 and 50 were identified in S and G2) were 
highly enriched in the presence of PP2ACdc55 activity, not its absence.  
 
 
 
 
 
 
 
 
 
Figure 4.13 –  Cdk phosphorylation on threonine, but not serine, residues is highly 
enriched in the absence of PP2ACdc55 activity 
(following page) 2D annotation enrichment analysis identifying enriched “categories” in 
the SILAC experiment, and a graphical annotation indicating whether any of these 
categories are more highly represented in the absence or presence of phosphatase 
activity, as in Figure 4.14, taking into account the two experimental repeats A and B. 
Categories enriched in the absence of PP2ACdc55 can be viewed in the top-left quadrant. 
The different categories of interest are indicated in colour.  
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4.7 Roles for Cdc14 or PP1 in interphase remain 
unsubstantiated 
As with PP2ACdc55, I studied the role of Cdc14 in interphase. I examined whether global 
Cdk phosphorylation levels were affected, as in Figure 4.4, and found no difference 
between the wild-type and a cdc14-1 temperature sensitive strain at restrictive 
temperature, in synchronous cell cycle experiments. Further, I was unable to identify 
any interphase Cdk target whose phosphorylation was advanced in the absence of 
Cdc14 activity. Finally, elimination of Cdc14 activity in a G2-arrested state, using either 
cdc28as-1 strains with varying concentrations of 1-NMPP1, or clb1Δ clb3Δ clb4Δ clb2-ts 
cdc14-1 strains at restrictive temperature, did not have any effect.  
Therefore, so far, I have been unable to demonstrate a role for Cdc14 in interphase in S. 
cerevisiae. The role of PP1 in interphase has yet to be examined.  
4.8 Discussion and conclusions 
4.8.1 PP2ACdc55 opposes phosphorylation of Cdk targets in interphase 
From the results of the SILAC screen comparing Cdk phosphorylation in the presence 
and absence of PP2ACdc55 activity, as well as from using anti-phospho-Cdk site 
antibodies, we can conclude that PP2ACdc55 has a global effect on Cdk phosphorylation 
levels in interphase.  
Further, I have also shown that the phosphorylation of three Cdk targets, Acm1, Sli1, 
and Ndd1, is advanced in the absence of PP2ACdc55 activity. 
Interestingly, a recent publication has stated that the stability of Ndd1 is controlled by 
APC/CCdh1, with Ndd1 being a target for ubiquitin mediated proteasomal degradation 
in early interphase, preventing the too-early transcription of mitotic genes (Sajman et 
al., 2015). This explains my personal observations that Ndd1 is absent in G1. I have 
shown here that Acm1, the stability of which is controlled by phosphorylation of a 
specific residue by Cdk, appears earlier in the cell cycle in the absence of phosphatase 
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activity, presumably due to advanced phosphorylation of the protein on this residue. 
Acm1 being a stoichiometric inhibitor of APC/CCdh1, this then implies that the early 
appearance of Acm1 could in fact lead to earlier inactivation of the APC. Supporting 
this hypothesis, Ndd1 also appears earlier in the absence of Cdc55.  
These results confirm our initial hypothesis, that Cdk-opposing phosphatase activity 
plays a role in interphase. However, our guess that phosphatases would be more 
important in G2 than in early interphase appears to be incorrect, at least when it comes 
to PP2ACdc55. Acm1 phosphorylation, normally occurring in late G1, seems to be 
advanced as much as Ndd1 phosphorylation, normally occurring in G2/M. Further, the 
results of the SILAC screen revealed a similar increase in Cdk phosphorylation levels 
whether the sample was taken in G1, S or G2, despite the G1 sample being taken before 
cells were released from α-factor, (thus pre-“Start”), with very low levels of Cdk activity.  
These results, however, have to be tempered by the mention of the fact that the timing 
of phosphorylation of several more interphase Cdk targets including Mms4 and Src1, 
amongst others, was not affected by the absence of Cdc55.  
4.8.2 PP2ACdc55 and Threonine dephosphorylation – a role beyond 
interphase?       
In fact, perhaps the most striking result from the SILAC screen was not that global Cdk 
phosphorylation levels were elevated in the absence of Cdc55, but rather that this 
increase in levels can be explained solely by an increase in phosphorylation on 
threonines, and not on serines. This could also provide a possible explanation for the 
fact that some Cdk targets are affected by the absence of PP2ACdc55 and others not – 
those with threonine, rather than serine, Cdk sites phosphorylated in vivo. Is this the 
case for Acm1, Sli15 and Ndd1?  
Strikingly, the sole Cdk site (out of 5) in Acm1 that has been shown to be important for 
its stability is T161, with the half-life of a non-phosphorylatable Acm1-T161A being 
significantly shorter than that of wild type Acm1 (Hall et al., 2008; Ostapenko et al., 
2008).  
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Moreover, the sole Cdk site in Ndd1 so far confirmed to be phosphorylated by Cdk in 
vivo, and to be important for the interaction of this protein with its binding partner 
Fkh2 and thus binding to the DNA, is T319 (Reynolds et al., 2003; Darieva et al., 2003). 
However, this is just one of seventeen S/TP sites within the protein, 10 threonines 
(including T319) and 7 serines.  
Which of the seventeen putative Cdk sites (14 SP’s and 3 TP’s) within Sli15 are 
phosphorylated in vivo has yet to be confirmed, although phosphorylation and 
dephosphorylation of 6 Cdk sites (5S/1T) within the microtubule binding domain of 
the protein is thought to be important for its function (Pereira and Schiebel, 2003). My 
observation that Sli15 is initially phosphorylated earlier in the absence of Cdc55 but 
reaches full phosphorylation at the same time as in the control could reflect the fact that 
initial phosphorylation may be occurring on the threonine residue but the bulk of 
phosphorylation occurs on serine residues.  
On a side-note, and of further interest in discussing the advanced phosphorylation of 
Sli15, is the observation that Aurora kinase (Ipl1) seems to be less active when Cdc55 is 
absent from the cell, specifically in S phase and G2, but not G1 (Section 4.7.2 and Fig. 
4.16). This indicates that PP2ACdc55 could be a positive regulator for this kinase at these 
cell cycle stages. In fact, Sli15 itself is a regulator of Ipl1; moreover it is thought to 
inhibit Ipl1’s activity when phosphorylated by Cdk. It can be conjectured that increased 
phosphorylation of Sli15 by Cdk in the absence of Cdc55 could lead to hypo-activation 
of Ipl1. This provides a possible explanation for the decrease in Aurora-phosphorylated 
peptides observed by SILAC in the absence of Cdc55.  
The fact that PP2ACdc55 seems to specifically oppose threonine phosphorylation leads us 
to ask whether it can only dephosphorylate threonines and not serines, a topic for 
further investigations. In fact, there is a precedent for this – Cdc14 has been shown to 
have a strong preference for serines over threonines (Bremmer et al., 2012).  
Coincidentally, in this study by Bremmer et al, Cdc14 was shown to be unable to 
dephosphorylate T161 in Acm1 in vitro. Previously, I postulated that the timing of 
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phosphorylation of this same residue during interphase might be controlled by the ratio 
of PP2ACdc55/Cdk activity in the cells.  
Further evidence for a preference for serines vs. threonines of Cdc14 came from 
substituting a threonine for a serine in an Acm1 Cdk-phosphorylated peptide (a 20-mer 
peptide phosphorylated on S31 in Acm1). In vitro, this resulted in a 3000-fold 
reduction in catalytic activity of Cdc14 towards the peptide (Bremmer et al., 2012). 
However, in vivo, Acm1 (and other phospho-threonine containing Cdk targets) are 
fully dephosphorylated during mitotic exit (Hall et al., 2008; Kuilman et al., 
2015).These results have led to the assumption that another phosphatase aside from 
Cdc14 is responsible for dephosphorylating pT Cdk phosphosites during mitotic exit.   
It is tempting to speculate that this is indeed the case, with the identity of this 
phosphatase being PP2ACdc55. Supporting a role for PP2ACdc55 in mitotic exit is the fact 
that anaphase is prolonged and cytokinesis is delayed in the absence of Cdc55 (Fig. 4.1). 
This does not fit with its known role as an inhibitor of mitotic exit (through opposing 
Net1 phosphorylation) – if this were the only function for PP2ACdc55 in mitotic exit it 
would be expected that absence of Cdc55 would shorten, rather than prolong, anaphase. 
The delay in mitotic exit in the cdc55Δ background has been previously reported, 
concomitant with a delay in Cdh1 dephosphorylation, and Cdc5 and Clb2 degradation, 
the latter of which I have also observed (Fig. 4.5) (Baro et al., 2013). I have also noted 
that high levels of Cdk phosphorylation persist throughout anaphase and mitotic exit in 
the absence of Cdc55 (Fig. 4.8). It has been proposed that PP2ACdc55 helps allow full 
activation of the MEN pathway in late anaphase by keeping Mob1 in a 
dephosphorylated and active state – which could (at least partly) explain the mitotic 
exit delay phenotype in cdc55Δ cells (Baro et al., 2013). My results open the possibility 
for a more direct contribution of Cdc55 to substrate dephosphorylation during mitotic 
exit. 
Given the delay in Clb2 and Cdc5 degradation, both of which are APCCdh1 substrates, it 
has been suggested that activation of APCCdh1 is compromised in this case, especially 
given that phosphorylation and dephosphorylation of Cdh1 on Cdk sites (by Cdk/ 
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Cdc14) is thought to control its activity (Morgan, 2007; Baro et al., 2013). On the one 
hand, it is possible that a delay in APC activation in cdc55Δ can be explained by 
compromised MEN activation (and thus compromised Cdc14 release) – however this is 
counterintuitive, as in the absence of Cdc55, Cdc14 is more, rather than less active. 
Another possibility is that PP2ACdc55 can directly regulate Cdh1 phosphorylation. 
Further, it is conceivable that PP2ACdc55 also regulates the phosphorylation state (and 
thus stability) of Acm1 at mitotic exit, as it does in interphase (Jaspersen, Charles and 
Morgan, 1999; Hall, Warren and Borchers, 2004). A small delay in Acm1 destruction 
was observed in my hands in the absence of Cdc55; whether this actually influences the 
timing of APCCdh1 activation remains to be examined.  
4.8.3 Future perspectives 
The role of Cdk-counteracting phosphatases in interphase is still far from clear. 
Notably, although I have shown that PP2ACdc55 opposes phosphorylation of Cdk targets 
in interphase, I have yet to find a phenotypic consequence for the absence of 
phosphatase activity. As such, cells lacking PP2ACdc55 activity do not progress through 
interphase any faster than control cells, or manage to successfully escape from a G2 
arrest caused by low Cdk activity.  
In order to verify that PP2ACdc55 activity in interphase is important in vivo, a careful 
analysis of the phenotype of cells lacking PP2ACdc55 activity will need to be carried out. 
It will be interesting to determine whether lack of Cdc55 could rescue milder cell cycle 
progression phenotypes due to reduced Cdk activity, such is the case with some single 
cyclin deletions, or the temperature sensitive G2/M delay caused by the cdc28-1N allele.  
Many Cdk targets are not affected by the absence of PP2ACdc55, and this phosphatase 
seems to mainly affect threonine phosphorylation. This makes it unlikely that it should 
be the main, or the only, Cdk-opposing phosphatase acting during interphase. This is 
particularly true if our hypothesis is correct and Cdk-opposing phosphatase activity is a 
necessary part of the quantitative model for the cell cycle.  
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It can be speculated that PP2ACdc55 is not acting alone in opposing Cdk phosphorylation 
in interphase. Although functions for PP1 and/or Cdc14 have not yet been validated, 
we cannot rule out that these phosphatases also have a role in interphase. Perhaps all 
three phosphatases, acting upon different targets, contribute towards the regulation of 
the timing of mitotic progression, playing their particular part in the quantitative 
model for the cell cycle. Much work remains to be done in investigating whether this is 
the case.  
Firstly, it will be important to investigate whether PP1 has any role in interphase. To 
this end, interphase Cdk phosphorylation could be examined in a glc7-ts mutant 
background, using the same strategies as those in the earlier sections of this chapter – 
looking at specific Cdk targets and global interphase Cdk phosphorylation by western 
blot, possibly followed by SILAC if the results are promising. 
It also seems likely that the three serine/threonine phosphatases, having some measure 
of overlapping activity (and therefore possibly acting towards the same targets) could 
compensate for each other. As such, investigating the effects of double phosphatase 
mutants (for instance, comparing swe1Δ, swe1Δ cdc55Δ, cdc14-1 swe1Δ  and cdc14-1 
swe1Δ cdc55Δ strains) to determine whether removing phosphatases together has 
additive effects, will be important. The timing of progression through interphase 
should be compared in these backgrounds, as well as levels of Cdk phosphorylation 
(using anti-phospho-Cdk antibodies). If results are promising, SILAC experiments can 
also be envisaged.   
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Chapter 5. Final Discussion 
In this thesis, I have provided new insights into the roles and regulation of Cdk-
counteracting phosphatases, both during mitotic exit and in interphase. 
5.1 Phosphatases are a vital component of the quantitative 
model for the cell cycle 
 I hope to have furthered our understanding of the quantitative mechanisms controlling 
the cell cycle.  
On the one hand, I have reinforced the idea that systems-level feedback plays an 
important role in cell cycle control, using budding yeast mitotic exit as an example. The 
fact that Cdc14 release is so stringently regulated, on so many levels, is yet another 
indication that the balance of kinase/phosphatase activities during this stage of the cell 
cycle is crucial for the timing of Cdk substrate dephosphorylation and thus cell cycle 
progression. The presence of the positive feedback loop for Cdc14 release in early 
anaphase allows for rapid amplification of Cdc14 activity, compensating for the adverse 
effect of Cdk downregulation on maintaining Net1 phosphorylation (and therefore 
Cdc14 release).  
More generally, the importance of feedback loops and ultra-sensitive mechanisms in 
cell cycle control, causing transitions between states to become both sharpened and 
irreversible, is becoming ever clearer (López-Avilés et al., 2009; Kapuy et al., 2009; 
Domingo-Sananes, Kapuy, Hunt and Novak, 2011; Jr, 2013; Santos and Ferrell, 2008). 
In particular, it has been highlighted in recent years through the use of computational 
modelling.  
On the other hand, I have established that the ratio of kinase/phosphatase activity is 
also a vital determinant for the timing of substrate phosphorylation during interphase. 
This is not in fact surprising, as the existence of this phosphatase activity has been 
postulated and even become an accepted part of cell cycle models in recent years (Barr, 
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Elliott and Gruneberg, 2011; Jr, 2013; Domingo-Sananes et al., 2011). However, this is 
the first formal demonstration that PP2A directly opposes phosphorylation of specific 
Cdk targets in interphase, independently of its role in regulating the activity of Cdk.  
Again, it will be important to understand how ordered target phosphorylation is 
achieved, from a quantitative point of view. Is it that phosphatase activity is constant 
during interphase and kinase activity is increasing, with some substrates more sensitive 
to the kinase but equally sensitive to the phosphatase, that causes the substrates to be 
phosphorylated in an orderly manner? If this were the case, the role of phosphatase 
activity would simply be to improve the time-resolution of phosphorylation; spreading 
substrate phosphorylation over a longer time-period than could be achieved with the 
kinase acting alone. Alternatively, it’s also possible that certain substrates are better for 
the kinase than for the phosphatase (and vice-versa), as during mitotic exit? In either of 
these cases, the biochemical basis behind substrate preference, either by the kinase or 
phosphatase, that causes them to be phosphorylated at a specific time, is an important 
area for further study.  
5.2 Future perspectives – moving on from budding yeast to 
other model organisms 
Finally, deepening our understanding of the roles of Cdk-opposing phosphatase 
activity in higher eukaryotes must remain our ultimate goal. We need to understand 
exactly how mitotic exit is controlled in other organisms, and validate the role of Cdk-
opposing phosphatases at this cell cycle stage. Indeed, it will be interesting to determine 
whether a preference for threonines over serines is specific to budding yeast PP2ACdc55 
(and in fact, within budding yeast, specific to this isoform of the enzyme), or conserved 
in different species.  
Given how stringently Cdc14 is regulated in budding yeast, we can reason that in other 
organisms, the mechanisms of regulation of phosphatase activity, restricting their 
activity to particular cell cycle locations and particular cell cycle times, will also be 
conserved. Recent studies are already giving indications as to how Cdk-counteracting 
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phosphatase activity is regulated in other systems, although it seems the more we 
understand, the more levels of regulation are being uncovered (Grallert et al., 2015a; 
Cundell, Bastos, Zhang and Holder, 2013; Glover, 2012; Grallert et al., 2015b; Schmitz 
et al., 2010).  
Although it seems logical that the quantitative model for cell cycle progression should 
hold true in more complex organisms, and some clues have indicated that the 
phosphorylation of at least a subset or proteins depends on the kinase/phosphatase 
ratio (Wolf, Wandke, Isenberg and Geley, 2006; Garriga et al., 2004), this has yet to be 
validated and remains a crucial area for investigation. Working towards this, some 
insights into the mechanistic basis for phosphatase specificity in early mitotic exit in 
mammalian cells have been recently provided (McCloy et al., 2015).  
Similarly, we need to move on from mathematical modelling of the (relatively simple) 
yeast or X. laevis embryonic cell cycles to modelling that of mammalian cells – 
incorporating phosphatase activity as a key determinant of the timing of cell cycle 
events and transitions in both systems.  
In a wider context, the ultimate aim of elucidating the mechanisms behind the control 
of cell division is to understand how perturbations in the human cell cycle machinery 
lead to the development of cancer. Accurate predictive models of the cell cycle could 
help in the development of new ways to target the weaknesses of cancer cells, or in the 
restoration of cell cycle control.  
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Chapter 6. Appendix 
6.1 SILAC screen (2) – additional data and controls 
As discussed in sections 4.5-6, a SILAC screen was carried out in order to compare Cdk 
phosphorylation at different stages in interphase between swe1Δ and swe1Δ cdc55Δ 
strains. As a quality control, experiments were performed in which at each time point 
(G1/S/G2), swe1Δ vs. swe1Δ (heavy/light) and swe1Δ cdc55Δ vs. swe1Δ cdc55Δ 
(heavy/light) were compared. No significant variation in phospho-peptide ratios was 
noted in any of the experimental samples. This includes all Cdk phospho-peptides, 
whether serine or threonine phosphorylated. Indeed, in each experiment, fewer than 
5% (and in general closer to 1%) of Cdk phosphorylated phospho-peptides were 
enriched in either the heavy or light cultures (Fig. 6.1). Importantly, as a control for the 
results of the 2D annotation analysis, TP phosphopeptides are not enriched in the 
heavy/light in any of the control experiments.  
By comparison, looking at the scatter plots for each individual sample mix, significant 
variations in phospho-peptide ratios (reflecting the fact that Cdk phospho-peptides are 
enriched in the absence of Cdc55, and more specifically TP phosphopeptides, as 
detailed in Fig. 4.13) are clearly noticeable. In fact, in each of these 6 samples, 
respectively between 10 and 25% of Cdk phosphopeptides are enriched in swe1Δ 
cdc55Δ vs. swe1 Δ, as compared to the 0-4% in swe1 Δ vs. swe1Δ cdc55Δ (Fig. 6.2).  
 
 
 
 
 
Figure 6.1 – SILAC quality control, swe1Δ vs. swe1Δ (H/L) and swe1Δ cdc55Δ vs. 
swe1Δ cdc55Δ (H/L) 
(following page) Ratio of heavy/light phospho-peptides versus peptide intensity, in G1, 
S and G2 in either swe1 versus swe1 (heavy/light) (A.) or swe1Δ cdc55Δ versus swe1Δ 
cdc55Δ (B.). Cdk phospho-peptides are indicated in green and blue, separated 
respectively into serines and threonines.  
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Figure 6.2 – Phospho-peptide ratios in each individual SILAC mix, swe1 Δ vs. swe1Δ 
cdc55Δ 
(previous two pages) Ratio of heavy/light phospho-peptides versus peptide intensity, in 
G1, S and G2 in either swe1 “heavy” versus swe1Δ cdc55Δ “light” (A.) or vice-versa (B.). 
Cdk phospho-peptides are indicated in green and blue, separated respectively into 
serines and threonines. 
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